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I. INTRODUCTION 
A recently completed handbook for the prevention and control of rheumatic fever 
(RF) and rheumatic heart disease (RHD) entitled RHD TIPS: Rheumatic Heart Disease Tools 
for Implementing Programs (RHD TIPS) was written by the World Heart Federation (WHF) 
and RhEACH. The document is a comprehensive outline of strategies and frameworks to 
help guide the design and implementation of successful RF/RHD control programming. 
Policy-makers around the world will use it to develop RF/RHD programs for inclusion into 
national non-communicable disease (NCD) plans. Nepal is one of five countries tasked with 
piloting the handbook’s recommendations. This masters paper will use the RHD TIPS 
handbook to guide RF/RHD prevention program development in Nepal. The handbook can 
be thought of as a quasi-evidence-based intervention from which countries can identify 
priority interventions to implement from a menu of options.  
At-A-Glance: Rheumatic Fever and Rheumatic Heart Disease 
If left untreated, a sore throat in childhood can cause death decades later. The 
pathogenesis of rheumatic heart disease (RHD) begins with a pharyngeal Group A 
Streptococcal infection—colloquially called “strep throat”—most commonly acquired in the 
elementary school years. Weeks after apparent clearing of the throat infection, 0.3% to 5% 
of children develop acute rheumatic fever (ARF) (Irlam, 2013). As part of this inflammatory 
process, 30-80% of patients will develop carditis due to auto-immune-mediated destruction 
of valvular heart tissue (Roberts, 2013). Approximately 60% of patients will subsequently 
develop RHD over a ten year period (Carapetis, 2005). Of those diagnosed with RHD, 
between 44% and 80% will develop severe heart failure if untreated, necessitating medical 
or surgical treatment within 20 years (Roberts, 2013). Mortality for untreated RHD is 
estimated at 1.5% per year (Carapetis, 2000). 
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The number of individuals living worldwide with RHD is estimated at 15-20 million 
(Maurice, 2013). Global incidence approaches 300,000 cases per year, similar in number to 
the estimated RHD global mortality rate of 233,000 deaths per year (Roberts, 2013). Global 
incidence and prevalence estimates, however, are limited by generally poor disease 
surveillance systems, variability in data collection methods as well as urban bias (Marijon, 
2007).  
RF/RHD in Nepal 
Nepal has some of the highest frequency rates of RF and RHD in the world. Based on 
echocardiographic screening campaigns of school-aged children in the capital city of 
Kathmandu and the Lalitpur district south of the city, the Nepal Heart Foundation estimates 
that the incidence of RF approaches 15,000 cases per year and that RHD is prevalent in the 
country at a rate of 2/1,000 children (Regmi & Wyber, 2013). Prevalence of RHD is likely 
higher in rural and poorer regions in the country, where access to health care is limited and 
human and resource shortages are the norm.  
An RF/RHD control program already exists in Nepal. It is funded by the Nepalese 
Ministry of Health (MoH) and facilitated by the Nepal Heart Foundation (NHF), an 
organization of cardiac specialists and medical professionals founded in 1988. NHF now has 
37 facilities located throughout the country. Program activities began in 2007 when NHF 
was granted $30,000 from the Nepalese government. Since that time, a concerted effort has 
been made to run RF/RHD prevention as a “diagonal” program, one in which vertical 
disease-specific interventions are made within the context of horizontal health systems 
strengthening. Core program objectives included early detection and registration of 
RF/RHD patients, establishment of facilities for the safe administration of antibiotic 
prophylaxis (secondary prevention), and the establishment of national priorities and 
guidelines. Baseline disease data using echocardiographic screening in school-aged children 
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have been collected, audits have been performed to monitor patient compliance to 
antibiotic prophylaxis, health workers have been trained and demand for clinical services 
has increased via large-scale education campaigns targeting the public. The program has 
also recently expanded to embrace primary prevention strategies; currently, a pilot 
program is being implemented in the Lalitpur district just south of Kathmandu ((Wyber & 
Regmi, 2013). Despite the tremendous progress, Nepal still faces challenges in expanding 
RHD services to its entire population, integrating its RHD program into a national non-
communicable disease plan, securing long-term funding and instituting monitoring and 
surveillance analytics to assess program outputs. 
Strategies for RF/RHD Prevention 
After over a decade of neglect and lost progress, the international community is 
reinforcing its efforts to combat RHD. In a major victory for RHD advocates, the World 
Health Organization (WHO) voted to include RHD in its Global Action Plan for the Prevention 
and Control of Non-Communicable 
Diseases (NCDs) in the spring of 2013. 
Debate exists, however, with respect 
to the method(s) of intervention. 
Because of the disease’s complex 
natural history, there are many 
potential points along the causal 
pathway at which to intercede.  
Primordial methods of intervention focus on reducing socioeconomic factors that 
contribute to RHD development. Examples include general anti-poverty campaigns as well 
as programs to expand health insurance coverage, recruit physicians to urban underserved 
districts, promote hygiene, and improve housing conditions to prevent overcrowding 
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(Webb, RF in NZ, 2011; Australia Guidelines, 2011). Creation of a vaccine against the 
capsular surface M-protein of GAS to prevent subsequent development of ARF can be 
considered primordial prevention, although some may consider vaccination as primary 
prevention.  Unfortunately, the time frame for development of an efficacious vaccine will 
likely be measured in decades, not years (Carapetis, 2007; Steer, 2013).  
The chief aim of primary prevention is to identify and treat symptomatic GAS 
pharyngitis. Primary prophylaxis is a two-step process. First, GAS sore throat must by 
diagnosed, but this diagnosis is tricky to make solely on clinical grounds. Only up to 30% of 
sore throats in the pediatric population are due to GAS and even fewer in the adult 
population (Irlam, 2013). Many clinical tools with varying efficacy have been developed to 
distinguish GAS pharyngitis from viral etiologies (Irlam, 2013; Nandi, 2002; Nordet, 2008; 
Arguedas & Mohs, 1992). In many developed countries, including the United States, children 
with clinically-suspicious GAS sore throat undergo a throat swab followed by a rapid-Strep 
test. Frequently, a back-up culture is grown overnight to compensate for the rapid test’s 
subpar sensitivity. In many parts of the world, however, this diagnostic capability is not 
feasible given resource constraints, making clinical diagnosis is the only viable option 
(Irlam, 2013). The second step is treatment after diagnosis. Fortunately, GAS remains 
remarkably sensitive to our most ancient antibiotic, penicillin, which can be administered 
both orally and intramuscularly (Kaplan 2012). Cuba and Costa Rica were both able to 
effectively eliminate RHD using primary prevention strategies coupled with large-scale 
awareness campaigns for citizens and providers (Nordet, 2008; Arguedas & Mohs, 1992). In 
South Africa, the use of a clinical decision rule tool coupled with injectable penicillin 
treatment was found to be the most cost-effective primary prevention strategy for children 
aged 3-15 years at $150 per QALY (Irlam, 2013).  
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Secondary prophylaxis involves the long-term provision of penicillin to individuals 
with a history of RF and/or a diagnosis of RHD. Prophylactic penicillin serves to prevent 
GAS pharyngitis and thus flares of RF. Frequency of RF recurrence is directly associated 
with severity of valvular disease and development of RHD (Bland, 1951). Monthly-
administered injectable benzathine penicillin G (BPG) is preferred to twice-daily oral 
penicillin G due to superior efficacy and compliance (Kaplan, 2012; Mayosi, 2009). Creation 
of a disease registry is essential in order to monitor follow-up. Because RHD is a progressive 
disease, it is likely beneficial to identify individuals early in their disease process. Therefore, 
active screening, which can be performed by auscultation for the presence of a suggestive 
murmur and by echocardiography, is used to identify asymptomatic and subclinical RHD in 
high prevalence populations. Debate exists in the RHD community, however, regarding the 
clinical importance of treating asymptomatic disease (Webb, Optmising, 2011). Secondary 
prophylaxis is purported as the most cost-effective RHD prevention tactic in certain 
analyses (Australia Guidelines, 2011; Colquhoun, 2009).  
Table 1. Comparison of Primary and Secondary Prevention Strategies  
STRATEGY PROS CONS 
Primary 
prevention 
- Upstream in causal 
pathway 
- Prevents RF (and its 
complications) 
- Prevents RHD 
- Effective treatment 
- Easy treatment 
compliance 
- ?Cost-effectiveness 
- Difficult clinical diagnosis for GAS 
pharyngitis 
- Access to primary health care required 
- Overtreatment, both of non-GAS pharyngitis 
and in those with GAS pharyngitis (only 0.3-
5% will develop RF anyway) 
- Expensive diagnostic tests (swabbing, Rapid 
test, culture) 
- Some populations have high rates of 
asymptomatic GAS pharyngitis (Aborigines) 
- ?Cost-effectiveness  




- Early detection of RHD 
- High sensitivity of echo; 
decent specificity 
- Effectiveness of 
treatment (BPG) 
- Covers populations with 
- Low sensitivity and specificity of 
auscultation 
- High cost of echocardiography 
- Does not prevent RF (and its complications) 
- Does not prevent RHD (only worsening) 
- Poor compliance with long-term BPG 
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Tertiary prevention strategies are those designed to reduce morbidity and avert 
complications of RHD. Interventions include medicating heart failure, anticoagulation for 
stroke prophylaxis and surgical repair of diseased heart valves (Australia Guidelines, 2011; 
Carapetis, 2007). Management of chronic RHD is exceedingly costly; paying for surgical care 
for one patient in many small Pacific Island countries, for example, is roughly equivalent in 
cost to the entire annual budget of a comprehensive national RHD prevention program 
(Colquhoun, 2009). In Nepal, a business case for prevention was made in order to 
circumvent the high costs associated with medical and surgical management of end-stage 
RHD (Regmi & Wyber, 2013).  
Framework for a Comprehensive RF/RHD Prevention Program 
 The RHD TIPS handbook includes a framework as a way to conceptualize the various 
components of a comprehensive RF/RHD program at the national level. At the bottom, large 
social issues, which are addressed by so-called primordial prevention strategies, are shown 
to underlie the higher-order prevention approaches. Components are ordered in order of 
priority, from bottom to top and left to right. The baseline rows include components 
thought to be fundamental to program success. Only when baseline components have been 
adequately addressed is it appropriate to consider implementing more specific and complex 
interventions.  
high rates of 
asymptomatic GAS 
pharyngitis 
- Active screening brings 





- Requires registry 
- Debate over need to treat asymptomatic 
disease; no data on effectiveness of treating 
subclinical RHD 
- Overtreatment (only 60% of patients with RF 
will progress to RHD; unsure about natural 
history of subclinical RHD) 
- Harms: anaphylaxis, disease label, time 
commitment 
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Table 2. RHD TIPS Conceptual Framework for Comprehensive RF/RHD 
Prevention 
 
It will be near impossible to address every component in the framework; local 
context and resource availability will dictate which components are prioritized. A baseline 
assessment tool provided in the toolkit will help program designers identify target 
components for intervention. Furthermore, because the framework was conceived and 
generated by Western academics, the author and the chief program administrator critically 
analyzed the utility of the RHD TIPS conceptual framework in the Nepalese setting.  An 
adapted version of the conceptual framework was generated and used to inform program 
design (Please see METHODS section under PROGRAM PLAN section).  
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II. SYSTEMATIC LITERATURE REVIEW 
Introduction 
 A wealth of information on past and extant RF/RHD programs can be found in the 
literature. During the planning process for any new program, it is prudent practice to 
review related prior experiences in order to build upon successes and avoid failures. A 
comprehensive search strategy was used to identify programs relevant to RF/RHD 
prevention in Nepal. In subsequent pages, these programs will be analyzed systematically in 
order to inform the Nepalese RF/RHD prevention plan.  
Methods and Search Strategy 
 The primary research question to be answered by this systematic review is: “What 
countries have implemented RF/RHD prevention programs and what can be learned from 
the relative successes and failures of these programs?”  
 I identified core references for worldwide RF/RHD programs via systematic review 
of the literature. EMBASE, BIOSIS and PubMed databases were searched using the terms: 
“rheumatic” AND (heart disease OR fever NOT arthritis) AND (control OR prevention OR 
prophylaxis) AND (progra* OR strateg*).” In addition, focused searches for specific 
components of control programs, including: “regist*,” “community education,” “training,” 
“anticoagulation,” “disease notification” and “surveillance” were completed. Articles 
published after 1952 were accepted. After this initial search, articles were first excluded 
based on title review. Abstracts of the remaining articles were assessed and those deemed 
irrelevant or unsuitable were discarded. Sentinel articles were identified and bibliographic 
review led to the inclusion of other references. Unpublished, informal “gray literature” was 
identified through review of institutional archives, including the World Heart Federation. A 
snowball approach was used to identify other source documents accessible through direct 
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contact with individuals and institutions. Participants in key informant interviews were also 
asked recommend other sources of unpublished gray literature.  
 In addition to the methods reviewed above, inclusion criteria requirements for this 
Masters paper included: a) the program must be designed specifically for RF/RHD 
prevention, b) the program must be implemented in a developing country or target 
vulnerable populations within developed country, and c) the program must be facilitated at 
the national level. Unfortunately, absence of an evaluation framework could not be 
considered as a reason for exclusion; to this date, only the WHO’s Global Programme for the 
Prevention of Rheumatic Fever and Rheumatic Heart Disease and New Zealand’s Rheumatic 
Fever Prevention Programme have established even a rudimentary evaluation framework. 
Other programs lacked a formal evaluation protocol. Importantly, the reports included in 
this analysis are comparative studies that use historical control groups; most programs 
simply compare pre- and post-implementation incidence and prevalence measurements. 
Thus, they are inherently limited in their ability to draw concrete conclusions unless one 
assumes that variables external to the intervention remain constant throughout the 
duration of the program. In total, five programs were selected for analysis. 
SUMMARY OF PROGRAMS 
WHO Global Program for the Prevention of Rheumatic Fever/Rheumatic Heart Disease 
In 1986, the WHO facilitated the roll-out of RF/RHD prevention programs in sixteen 
countries in highly endemic regions throughout the world. The programs were managed by 
Ministries of Health in the participating countries.  
Description 
In a step-wise fashion, the program was rolled out in each participating country, 
first at a pilot site, then expanded into surrounding communities and finally scaled-up to the 
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national level. In exchange for technical protocols, educational materials as well as financial 
and moral support from WHO, countries were expected to submit semi-annual progress 
reports to WHO. Secondary prevention was the initial focus of the Global Programme, 
although after establishment of secondary prevention programs seven countries opted to 
develop primary prevention projects. To facilitate the formation of secondary prevention 
programs, WHO urged countries to create central registries for data collection and patient 
follow-up purposes. In order to recruit cases for the registries, active case-finding was a 
critical component of the program. Cases were identified by hospital record review as well 
as by direct questioning of school-aged students and their families for signs and symptoms 
consistent with a diagnosis of RF/RHD.  
Awareness-raising campaigns underlay all other program activities. Program 
administrators preferred print media—including booklets, brochures, pamphlets and 
posters—to other forms of media because of their reproducibility, conciseness, ease of 
distribution and permanence.  For example, providers can use print media guides to quickly 
refresh medical knowledge and RF/RHD management guidelines. Patients can refer to 
handouts to learn about their disease and remember follow-up recommendations. Mass 
media, including radio and television, were used in certain settings. Messages conveying 
safe hygiene practices and healthy lifestyle promotion were delivered directly to students in 
schools. A direct correlation was seen between the amount of education provided and the 
number of patients registered and compliant with secondary prophylaxis. An unstable 
supply of BPG, inadequate staff and weak reporting were all associated with lower rates of 
compliance (WHO, 1992). 
 Encountered challeges included follow-up for secondary prophylaxis ,which 
requires monthly injections of benzathine penicillin G (BPG). For patients living far away, 
time and transportation were barriers to care. Program administrators recommended 
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decentralizing BPG dispensation to smaller and smaller health posts. Swabbing and culture 
were considered untenable for primary prevention activities because of cost and because 
low rates of patient return visits to clinics to receive a definitive diagnosis.  Provider 
knowledge of RF/RHD diagnosis and management naturally wanes with time, especially 
with a disease like RF/RHD that is relatively rare. Providers, therefore, must be periodically 
reminded of clinical best practices, and print media were used as quick references 
resources. 
Program sustainability was threatened after funding from AGFUND (Arab Gulf 
Programme for United Nations Development Orgnaizatoins) expired. The lack of a small 
financial incentive was likely responsible for a reduction in country reporting rates to WHO. 
International camaraderie amongst Global Programme participants waned over time, 
further resulting in decreased country engagement with WHO. High turnover of program 
staff at the country level was common. Program implementers believed it was crucial for 
each country to have a dedicated and passionate local RF/RHD “champion” to advocate 
continuously to the Ministry of Health, whose support is vital in order for any program to 
maintain stability over time.  
Strengths 
 The Global Programme set an explicit goal: to “reduce morbidity, mortality and 
disability caused by RF/RHD through the establishment of at least one local/regional 
program implementing RF/RHD measures” (WHO, 1999). Consistent with this goal, RHD 
prevalence rates per 1000 schoolchildren were reported in certain countries before (1986) 
and after implementation of the program (1998): Cuba (2.3, 0.2), Egypt (7.2, 2.3), the 
Philippines (1.0, 1.0), China (0.8, 0.3) and India (3.0, 1.4). WHO did monitor intermediate 
outcomes according to world region in the form of “activities of health education,” the 
number and type of health personnel trained, number of screening surveys administered, 
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number of cases detected and registered as well as BPG compliance and adverse reactions. 
Absolute numbers of pamphlets and posters distributed, radio and television programs and 
groups sessions were recorded. Screening campaigns throughout the world helped to 
provide an epidemiological baseline for burden of disease estimates. WHO provided work 
plan tables, intervention timelines, checklists, clinical guidelines, registry forms and 
diagram models for various phases of the program in an effort to standardize 
implementation (WHO, 1992). Some may consider standardization a weakness in this global 
context, however, as fidelity is prioritized over adaptability.  
Weaknesses 
 The reliability of prevalence estimates is questionable, therefore compromising the 
internal validity of the program results. Many different methods were used for case-finding 
(surveys of schoolchildren, hospital retrospective case surveys and prospective detection in 
any clinical setting), all of which are inherently flawed and none of which approach the 
sensitivity and specificity of gold-standard echocardiography. It is unclear who performed 
the case-finding surveys (doctors, public health professionals, trained lay people, etc) and 
where the case finding was carried out (urban versus rural settings). Answers to these 
omissions may reveal further biases. Further, no data was reported on the relative 
strengths/weakness of the various case-finding methods and it is unclear which method(s) 
different countries used for detection. One can assume, therefore, that reported results 
reflect significant measurement bias. In addition, no formal theoretical model of program 
planning was used to guide program development.  
Costa Rica 
In 1968 an RF/RHD prevention program was established in Costa Rica at the 
National Children’s Hospital in San Jose. The program was scaled-up in 1970 and piloted in 
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a single province before becoming a formal, permanent national program in 1972. Arguedas 
and Mohs outlined the program and documented its success in their 1992 paper (Arguedas 
& Mohs, 1992) in The Journal of Pediatrics.  
Description  
Primary prevention is the central focus of the program. In Costa Rica in the early 
1970’s, diagnosis and management of GAS pharyngitis was suboptimal. Program designers 
decided to eliminate throat swabbing and culture as a prerequisite for antibiotic treatment; 
diagnosis of GAS pharyngitis was henceforth made solely on presenting clinical signs and 
symptoms. This was both a practical cost consideration as well as an attempt to avoid the 
return visits required for swabbing/culture follow-up. In addition, the treatment modality 
was switched from 10-day procaine penicillin to a one-time benzathine penicillin G (BPG) 
injection in order to increase compliance. It was shown in a prior research study that 
children were only receiving, on average, 1 to 3 shots of the 10-day course of procaine 
penicillin.  As a result, BPG was given to every patient who met the clinical criteria for GAS 
pharyngitis: “every patient who consulted because of fever or sore throat and whose 
physical examination showed halitosis, redness of the pharynx, and hypertrophy of the 
tonsils with a white exudate.” This intervention, led to a significant drop in the incidence of 
ARF and RHD in Costa Rica: in the early 1970’s the incidence of RF was 90 cases/100,000 
inhabitants/year; by 1990 the incidence dropped to 1/100,000/year (Arguedas & Mohs, 
1992).  
Ancillary program activities provided a favorable context in which the new clinical 
guidelines for sore throat management could succeed. At the time, the government was 
actively extending and improving the nation’s primary care workforce. In addition, 
governmental support and funding for the RF/RHD prevention program ensured the 
program’s long-term survival. Intense and widespread awareness campaigns for the public-
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at-large were carried out to increase demand for treatment of sore throat. In addition, 
public education campaigns stressed hygiene, nutrition and overcrowding. Clinicians, 
nurses and other health care workers were educated about new clinical management 
guidelines and were adequately supplied with BPG necessary to treat cases of suspected 
GAS pharyngitis. RF/RHD became part of the training curricula for health professionals in 
the country. Patients identified as having RF and RHD were entered into a centralized 
register for follow-up care. 
Strengths 
 The Costa Rican program benefitted from strong governmental support, which 
resulted in a robust BPR procurement system and program sustainability. “Diagonal” 
integration into an improving primary health care system was a major component of the 
program that likely enhanced its effectiveness. As part of this process, decentralization of 
service delivery was augmented. In addition, the frequency of adverse events to penicillin 
was monitored and development of microbial resistance to treatment was tracked in the 
laboratory. Adverse events to penicillin were found to be extremely rare and always non-
fatal. Likewise, GAS remained highly sensitive to penicillin throughout the program’s 
duration and has maintained sensitivity to this day.  
Weaknesses 
 The program design was not informed by a theoretical framework. Again, there was 
no control group. Therefore it is theoretically possible, albeit highly unlikely, that RF/RHD 
rates would have decreased similarly in the absence of the program. For example, some may 
argue that a strengthening primary care system itself was responsible for the declines in 
RF/RHD rates. Lack of an evaluation framework meant that outputs were not monitored. 
Evaluation would have been strengthened by monitoring intermediate indicators, like 
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number of health care workers trained, number or newspaper articles written/pamphlets 
distributed/batches of BPG disbursed, among others.  
Samoa 
 The Samoan Rheumatic Fever Programme has existed since 1984 (Viali, 2006). 
More recently, funding from NZAID (New Zealand Aid) and Vodafone foundation, as well as 
technical support from WHF and professionals a Menzies Research Center in Australia, has 
boosted Samoa’s capacity to expand their prevention program, which is focused on 
secondary prevention (Viali & Saena & Futi, 2011).  
Description 
 Pacific Islanders exhibit some of the highest rates of RF/RHD in the world (Steer & 
Colquhoun & Viali, 2006). Secondary prevention, as opposed to primary prevention, was 
pursued in Samoa for a few reasons: 1) Samoans tend to present with late-stage RHD, 
suggesting that many patients are asymptomatic during GAS pharyngitis and ARF flares 
(Viali, 2006; Viali & Saena & Futi, 2011) and, 2) large-scale screening campaigns are 
considered more feasible in smaller nations, especially island nations.  
 The project was administered at Samoa’s National Hospital in the capital of Apia. 
There, a centralized electronic registry was created that collated diagnoses of both RF and 
RHD from centers throughout the country (Viali & Saena & Futi, 2011). Patients from 
throughout the country come to the National Hospital to receive secondary prophylaxis in 
the form of monthly BPG injections, a process facilitated by concurrent improvement in 
transportation infrastructure. Mobile clinics equipped with portable echocardiography are 
also used to reach remote populations. Since the program’s inception, compliance rates—
assessed by number of injections per patient per year—have improved from <50% in the 
years 2001-2006 to approximately 80% in the years 2007-2009. In addition, the incidence 
   17 
of RF has decreased from 30/100,000 in 2005 to 9.5/100,000 in 2009, and the prevalence 
of RHD has decreased from 40.2/100,000 in 2007 to 31.8/100,000 in 2009 (Viali & Saena & 
Futi, 2011). 
 Public and provider education helped scale the program’s reach. Workshops were 
provided for medical staff and mass media outlets, mainly in the form of TV documentaries 
and newspaper articles, were used to increase public demand for screening and treatment 
(Viali, 2006; Viali & Saena & Futi, 2011). A 2011 non-randomized qualitative study7 
analyzed the efficacy of RF/RHD information dissemination to parent groups in Samoa 
using a pre/post-survey design. The study utilized theory of the Social Change Model and 
targeted the interpersonal level of the Social Ecological Model. Analysis revealed 
statistically-significant increases in knowledge exchange using this method, and the authors 
propose that knowledge dissemination strategies are a cost-effective way in which to 
reduce RF/RHD incidence (Allen, 2011). 
There was a subsequent effort, in 2003, to integrate primary prevention efforts into 
the existing program (HRPIRD, 2003). This program, entitled the Rheumatic Fever School 
Program, targeted high-risk schools as identified by previous prevalence studies. The 
Ministry of Health and the Ministry of Education, Sports and Culture have collaborated to 
design a program whose core component is to use teachers to refer children with sore 
throat to appropriate clinical staff, in this case, local district nurses who are trained to 
diagnose GAS pharyngitis and administer proper treatment (Viali, 2006). Data pertaining to 
the effectiveness of this program is not available.  
Strengths 
 Government is intimately involved with the design and funding of the program. Due 
to resource constraints, the government has reached out to stakeholders to supplement its 
efforts—foreign governments, international NGOs, IGOs and even visiting surgical teams 
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from abroad—resulting in a strengthened national program. Although not included in the 
program description above, rudimentary cost-benefit analyses have been performed by the 
government. Caring for end-stage RHD patient in the hospital and sending patients to New 
Zealand to undergo cardiac surgery was deemed unsustainable from a financial standpoint. 
The prevention program, therefore, is viewed as a cost-effective way in which to decrease 
burden of disease due to RF/RHD.   
Weaknesses 
The Samoan program is plagued by similar critiques already listed above. That is to 
say, no formal “research” has been performed to monitor or evaluate the program’s 
effectiveness. By its very design it is impossible to do so: there is no control group as the 
entire country can be considered the intervention group. Even intermediate outcomes were 
not reported, which may have included number of health care workers and teachers 
trained, number of educational materials disseminated and percentage of students 
screened, for example.  
Rwanda 
The A.S.A.P. (Awareness, Surveillance, Advocacy, Prevention) Programme approach 
to RHD prevention operates in a number of African countries (Robertson & Vomink & 
Mayosi, 2006). In Rwanda, one of the project sites is in the Gasabo district in the capital city 
of Kigali.  
Description 
In Gasabo, 10 sites were selected to generate a representative sample of both urban 
and rural schools. Children at these schools were screened for RHD using echocardiography 
in a study designed to quantify the burden of disease attributable to RHD in school-aged 
children in Rwanda. Prior to screening, teachers, students, parents and health workers 
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received RF/RHD education and print media—including a booklet for patients with 
RF/RHD, a protocol for BPG administration, medical management guidelines and 
cardiovascular disease prevention, which were distributed with the help of a grant from the 
World Heart Federation. Nurses at local health centers were trained in RF/RHD prevention 
and treatment.  
The WHF echo criteria were used to diagnose RHD during the screening campaign 
(Remenyi, 2012). Three thousand children, aged 6-16 years old, were randomly selected 
from 10 schools. Plans are under way to expand the echo screening to another high 
prevalence region in the country to corroborate the initial findings: prevalence of 6.8/1000 
in Gasabo. Children who are echo-screened positive for RHD are started on monthly BPG 
injections. Plans are in place to establish 6 “Points of Care” throughout the country where 
patients identified as having RHD, and those who have undergone surgical mitral valve 
repair, can receive follow-up care. At these sites patients would be seen by doctors or 
nurses and cardiologists would supervise them by phone or internet. It is hoped that 
portable echo machines become available so that these machines can be rotated between 
the points of care on a monthly basis. In the near future, 6 physicians will enroll in a 2-year 
course on echocardiography so that local dependence on foreign experts to perform 
screening is reduced. 
Due to the collective efforts of the RHD community in Rwanda, the A.S.A.P. RHD 
model will be incorporated into the national strategic NCD plan. Collaboration between the 
RHD community and the Ministry of Education is strengthening, and progress is being made 
toward the inclusion of RHD in a national school health program. The school-based health 
care will ensure that a nurse from a local health center is responsible for providing holistic 
care for students in schools, including GAS pharyngitis treatment and referral of patients 
with symptoms of RF/RHD. Efforts are being made in tandem with the national Treatment 
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and Research AIDS Center to add RHD to “TRACnet,” a mobile phone-based application that 
is used to monitor HIV patients. Advocacy work is ongoing to establish a cardiac surgery 
program in Rwanda; currently RHD patients must travel internationally for surgery unless a 
foreign team of surgeons is visiting.  
Strengths 
 Rwanda’s A.S.A.P. RF/RHD prevention program is still in its infancy. Before full-scale 
implementation of any RF/RHD program, it is important to establish baseline prevalence of 
disease and the program has done this in the Gasabo region. Rwanda has made partnerships 
with outside organizations like Team Heart based out of the United States that focuses on 
tertiary surgical care of end-stage RHD patients. Government involvement is increasing and 
the program will be integrated into the national NCD plan. Rwanda is pursuing some 
innovative methods by which to scale the program, including partnering with the Ministry 
of Education to incorporate RF/RHD prevention messages into standard educational 
curriculum and using mobile technology to track patients. At this early stage of program 
implementation, there is likely still time to include a monitoring and evaluation framework 
into the program design. 
Weaknesses 
 Rwanda desperately needs to establish a functional registry if its focus on secondary 
prevention is to succeed. The program is not comprehensive in that it does not also allocate 
resources to primary prevention. No evaluation framework exists to monitor program 
effectiveness. Scalability and sustainability are of concern given reliance on 
echocardiographic screening, which is costly.  
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New Zealand 
 New Zealand’s Rheumatic Fever Prevention Programme, originally implemented in 
2011, is a coordinated effort directed by the Ministry of Health. Striking geographic 
variability in ARF and RHD incidence rates exists in New Zealand: the northern half of the 
North Island possesses the highest incidence rates. Auckland, which is located in this 
northern region, is a microcosm of the country’s ethnic and socioeconomic divisions. South 
Auckland, inhabited principally by poor indigenous populations, can claim the highest 
measured incidence rates in the country and the world (Webb & Wilson, 2013). Even within 
a district, however, prevalence of RHD can vary across ethnic groups. In the Hamilton health 
district just south of Auckland, overall prevalence ratios of 6.5/1,000 in Maori and 
0.9/1,000 in non-Maori were reported (Steer et al, 2002). Over 90% of RF cases in New 
Zealand occur disproportionally in the Maoiri and Pacific Islander children, only 36% of the 
total population in this demographic (Jacobs, 2014). According to government, RF/RHD is 
considered a “sensitive indicator” of child inequality (Liddel, 2010). A stated goal of the 
national RF/RHD program is to equalize incidence and outcomes of RF between indigenous 
and non-indigenous children (Litmus, 2013). New Zealand recognizes RF/RHD prevention 
as one of its top public health priorities as evidenced by its inclusion as one of the “Better 
Public Services” targets (Jacobs, 2014).  
Description 
 Primoridal and primary prevention strategies feature most prominently in the New 
Zealand Rheumatic Fever Prevention Programme. Initiatives around the country focus on 
one of two program prongs: “Stop It” (prevention of transmission) or “Treat It” (NZ 
Treasury, 2013). Initiatives falling under the “Stop It” prong are focused on primordial 
prevention, epitomized by the Auckland Healthy Homes Initiative, as well as community 
awareness raising. The housing initiative aims to equip health professionals with tools 
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needed to refer patients with housing-related health issues to proper welfare and housing 
services. The awareness-raising initiative utilizes a “door-knocking” service to deliver 
culturally appropriate RF/RHD educational messages to indigenous populations in 
Auckland. Homes, churches and community groups will all be targeted as sites of 
intervention. Furthermore, in early 2013, the Prime Ministers of New Zealand and Australia 
pledged $3 million USD in matching funds towards research to develop a vaccine for 
rheumatic fever (Office of John Key, 2013).  
 The “Treat It” prong is focused on primary prevention of GAS pharyngitis by the 
creation of school-based sore throat swabbing clinics and nurse-led community “drop-in” 
clinics. A meta-analysis of school-based primary prevention interventions showed a relative 
risk of 0.41 for development of ARF (95% CI 0.23-0.70, p=0.001) (Lennon et al, 2009). 
Furthermore, a systematic review determined that prompt diagnosis and treatment of GAS 
pharyngitis can reduce RF incidence in pediatric Maori and Pacific Islander populations in 
New Zealand (Kerdmelidis, 2010). 
 The Ministry of Health commissioned an implementation and formative evaluation 
report that was published in early 2013 (Litmus, 2013). Implementation successes were 
noted, including high provider dedication to the program, focus on creation of strong 
community links and networks, strong support from participating schools, and anecdotal 
evidence of high GAS detection rates. Qualitative surveys were administered to discern 
provider, caregiver and patient knowledge, awareness and satisfaction as well as to seek 
input for program recommendations. Threats to sustainability were identified: 1) growth of 
school-based swabbing services has outpaced awareness, especially in the primary care 
health system and, 2) awareness has focused on swabbing services and neglected the 
importance of seeking care in the primary health care system. To this point, it is believed 
that only 1/3rd to ½ of at-risk children undergo swabbing in schools. Evaluation consultants 
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recommended targeting implementation to areas with highest incidence of GAS, 
decentralizing administration to local District Health Boards, raising awareness amongst 
primary health care providers, and developing referral pathways for identified patients.   
Strengths 
 The New Zealand program includes a robust evaluation framework. The evaluation 
protocol includes both qualitative and quantitative indices. Importantly, input is solicited 
from community members, staff and other stakeholders for program improvement. 
Recognition of the importance of interventions at the primordial level suggests that the 
Ministry of Health is dedicated to addressing the underlying socioeconomic risk factors of 
disease transmission.  A focus on primary prevention over secondary prevention is 
inherently preferred as it not only prevents development of RHD, but also antecedent RF. 
The comprehensive nature of the plan, however, also covers secondary prevention using 
echocardiographic screening programs in schools. Government has explicitly stated that 
RF/RHD prevention is a national priority, especially given that it is considered an indicator 
of child inequalities, and has acted on this assertion by allocating adequate funds to cover 
program costs and targeting the most vulnerable populations. Innovative evidence-based 
(Lennon, 2009; Kerdemelidis, 2010) methods have been used to expand primary prevention 
services to children of school age: school-based sore throat clinics as well as “drop-in” 
clinics staffed by nurses.  
Weaknesses 
 The New Zealand Rheumatic Fever Prevention Programme is the most 
comprehensive of the programs included in this literature review. Even so, the program’s 
design is not guided by theory. In addition, because the program attempts to intervene in so 
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many ways (likely a very good thing), it is difficult to determine the relative effectiveness of 
any single program component.  
Analysis and Conclusions 
 The programs analyzed approach RF/RHD prevention in various ways, illustrating 
the many possibilities for intervention along the disease’s causal pathway. Resource 
availability, support from government, local epidemiology and other considerations likely 
influence program design in different countries. Comfortingly, all programs, regardless of 
their prevention strategy(ies), have displayed positive results, identified mainly by 
reductions in RF incidence and RHD prevalence (it is too early to measure post-
implementation rates in Rwanda and New Zealand, but program implementation in these 
countries is in and of itself can be considered a positive development). Unfortunately, the 
relative effectiveness of the various strategies remains unknown. Large-scale studies, 
including randomized-controlled trials, which compare one intervention strategy to another 
within or between countries do not exist. As mentioned previously, “studies” that use 
historical controls—like those most common in RF/RHD prevention—are inherently 
weaker than prospective cohort studies, including RCTs. Further, evaluation frameworks 
are rarely incorporated into RF/RHD prevention program design. Only the New Zealand 
program contains a robust evaluation framework, likely because of the country’s relative 
wealth. Program evaluation is costly and may exceed the capacity of already-thin budgets in 
many developing countries. Even in New Zealand, theory was not used to guide program 
design. RF/RHD prevention efforts would likely benefit from a theory-based approach to 
program design.  
 A shared component in every program was education and awareness-raising. Small 
print media, mass media outlets and face-to-face information exchange were all used to 
target patients, caregivers, staff and providers. Many programs use schools as a setting for 
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information dissemination (Rwanda, Samoa, New Zealand). Innovative techniques are being 
utilized, evidenced by the use of mobile technology and remote provider consultation in 
Rwanda.  
Implications for Nepal 
 The RHD TIPS handbook advocates for an evidence-based “comprehensive” program 
with elements targeting all levels of prevention. Of the programs analyzed in this review, 
New Zealand’s program is most representative of this ideal, but Nepal does not have the 
financial means to support a program as well-funded. The Nepal RF/RHD prevention 
program will, however, benefit from government support if political stability is maintained. 
In addition, a basic program infrastructure already exists in Nepal with implementation of 
both primary and secondary prevention measures.  
Similarly to Costa Rica, the RF/RHD program in Nepal is poised to benefit from 
improving housing conditions and a strengthening primary health care system. Primary 
prevention, then, will ideally be decentralized to local clinics. In order for primary 
prevention to succeed at the local level, an algorithm for the clinical diagnosis of GAS 
pharyngitis specific to Nepal will need to be developed. A pilot primary prevention program 
is underway in the Lalitpur district and information gleaned from this program will guide 
extension into other regions. Secondary prevention using echo screening in schools can also 
be scaled to more regions in the country, although it is not possible in the short- to medium-
term to scale nationwide as in Samoa. Not only will more children with RHD be identified 
and registered for secondary prophylaxis, but prevalence rates in different regions can 
inform program development and prioritization of resource allocation to areas with highest 
disease burden, as is occurring in Rwanda.  
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III. PROGRAM PLAN 
CONTEXT 
At-A-Glance: Nepal Country Profile 
 Nepal is a majority Hindu country located just north of India and south of Tibetan 
China in the heart of the Himalayas. Nepali is the native language, although English is an 
official state language widely spoken by those in government, business and the medical 
professions. Just over 30 million people live in Nepal (UN Dept. of Economic and Social 
Affairs, 2013) with 35% aged under 15 (WHO: Nepal Statistics Summary, 2014). 
Kathmandu, the capital, is a city of just under one million inhabitants. Although 
urbanization characterizes overall internal migration patterns, 80% of the population is 
rural with a large proportion living in remote, hard-to-reach mountainous regions of the 
county (Wyber & Regmi, 2013). A large majority of health resources, human and 
infrastructural, are concentrated in the urban areas (Shrestha & Bhandari, 2012). 
 From 1996-2006 Nepal experienced significant political unrest due to a Maoist 
uprising that resulted in the internal displacement of certain sectors of the population as 
well as violence leading to many deaths.  National elections were recently held in Nepal and 
the Maoist Party was roundly defeated by the more centrist Nepali Congress Party that 
ushered into power. Nepal is restructuring its health care system from a centralized model 
to one in which health service delivery and planning is increasingly made at state- and 
district-level; this reflects a concurrent overhaul of the structure of government in the 
country trending towards decentralization (HEART, 2013). Government expenditures on 
health care in Nepal constitute approximately 7% of GDP, but around 70% of health care 
expenditures are out-of-pocket payments borne by consumers (Jha, 2007). Nepal has a 
mixed public-private health care system. 
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Although great strides have been made recently to improve Nepal’s health care 
service and delivery mechanisms, crude health indicators—including life expectancy at 
birth, maternal and child mortality rates, among others—show significant room for 
improvement. Nepal is on target to fulfill the Millennium Development Goals (MDGs) 
number 4 (child survival) and 5 (maternal health), as well as MDGs related to malaria and 
TB. MDGs related to nutritional disease will likely not be met, however. As Nepal transitions 
to a more developed and urban society, non-communicable disease rates are expected to 
increase. Currently, the three most common preventable diseases are WaSH-related (water, 
sanitation and hygiene). These diseases preferentially affect children, causing respiratory 
and diarrheal illnesses that constitute a large majority of child deaths in Nepal (WHO|Nepal, 
2013).  
Nepal is still very much a developing country; its human development index is 0.48, 
ranking it 157th out of 187 countries, lower than the South Asian average and many sub-
Saharan African countries (UNDP, 2011). Twenty-fiver percent of the population lives 
below the poverty line. Women, certain ethnic groups and the geographically-isolated are 
overrepresented in poverty statistics (HEART, 2013) and associated with lower rates of 
health literacy (Shrestha MK, 2014).  
Folk beliefs regarding medicine are still widely held in Nepal. Priests and 
astrologers are often consulted by the ill, and numerous deities are believed to cure patients 
of infertility and skin diseases, for example (Wasti, 2011). Other beliefs and societal norms 
have made anti-retroviral adherence for HIV difficult in Nepal: the stigmatization of disease, 
the consideration of sex and sexuality as taboo topics, a positive valuation of shyness that 
creates “culture of silence” around sex, and the subordinate status of women in marital and 
sexual decision-making (Wasti, 2011). It is clear that the delivery of RF/RHD health care 
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services will occur in the context of the population’s existing health beliefs and societal 
norms. 
Nepalese National Health Goals and WHO Collaboration 
It will be very important for the national RF/RHD program to align with the 
Nepalese government’s overarching strategic goals in order to ensure its seamless 
integration into the health system. The program will benefit from existing health 
infrastructure and health systems strengthening, but will be constrained by system 
inefficiencies and resource constraints. 
In 2010, the Ministry of Health of Nepal drafted the Nepal Health Sector Programme 
II (NHSP II), which outlined the country’s health goals for the period 2010-2015. A mid-term 
report completed in 2013 analyzed progress made on selected goals and outputs, which 
included: improved service delivery (progress), improved health sector management 
(progress), reduced cultural and economic barriers to accessing health care services 
(progress), strengthening human resources for health (limited progress), improved M&E 
(progress) and sustainable health financing (limited progress) (HEART, 2013). In line with 
the NHSP II, the WHO has identified target areas for cooperation with the Nepalese 
government: achieving communicable disease objectives, controlling the growing NCD 
burden, improving health of most vulnerable populations, health systems strengthening via 
an improved primary care health system, reducing consequences of natural disaster and 
addressing environmental determinants of health including WaSH-related disease 
(WHO|Nepal, 2013). 
Because of the WHO General Assembly’s vote to include RHD in the Global Action 
Plan for the Prevention and Control of NCDs, decisions concerning RHD programming will 
likely be made in the context of NCD policy-making. WHO requests that Member States 
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develop long-term national NCD plans. RHD will feature in these policy documents, a crucial 
inclusion that is likely to result in fewer funding barriers for RHD initiatives. 
 Stakeholders outside of government include WHF and RhEACH, among other NGOs. 
These organizations have given mini-grants to NHF in the past. Additionally, these 
organizations, along with the WHO, serve as resources for technical expertise. Foreign 
governments and donors are likely to fund a large percentage of the Ministry of Health 
budget: in 2004, 30% of the total budget for health expenditures came from overseas 
funding. 
THEORY 
The program plan will be comprehensive in that it will target multiple levels of the 
social ecological model and utilize many different prevention strategies—from primordial, 
or social, interventions to primary, secondary and tertiary interventions. Within the larger 
framework of the social ecological model, components of other theoretical models will be 
used to guide intervention design. One of these models is the RHD TIPS framework detailed 
above.  
Individual level  
At the individual level of the social ecological model, many factors related to the 
development of RF/RHD are not plausible targets for any intervention. Unmodifiable 
individual risk factors, for example, include one’s genetic code, age and race. Nutritional 
status, poverty status and lack of health insurance, among other factors, are all individual 
social determinants of health, but they are only modifiable to a certain extent by behavior 
change at the individual level.  Often, societal level change is needed to raise the nutrition 
status of the population as a whole, decrease the poverty rate and provide health care 
access to all. However, behavior change to improve utilization of health care services and to 
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change attitudes regarding modern medicine, for example, can be modulated using the 
Health Beliefs Model (Rosenstock, 1966). The model proposes that individual’s health 
behaviors are dictated by four factors: perceived risk of disease, perceived severity of health 
outcome, belief that the intervention will produce a positive outcome and perceptions 
regarding barriers to seeking and obtaining care (Carpenter, 2010). Therefore, it is 
important to gauge perceived personal susceptibility to RF/RHD; perceived benefits, harms 
and self-efficacy of the medical management of RF/RHD; barriers to care and conditions 
thought to be prerequisite to seeking care. Myths and barriers can then be addressed via 
education, outreach or other higher-level interventions in order to elicit positive health 
behaviors. A community diagnosis—in the form of a needs assessment survey, focus group 
or other research method—will be useful in characterizing the local health beliefs and 
identifying knowledge gaps. Indeed, a short-term objective of this program is to perform a 
needs assessment during early implementation. Furthermore, health beliefs can be 
addressed by including lay persons, patients or caregivers on advisory committees along 
with other stakeholders during the program’s planning stages.  
Interpersonal level 
 According to Social Learning Theory (Bandura, 1971), interpersonal and human-
environment relationships affect individual behavior and may increase or decrease risk for 
any disease. RF/RHD, although categorized by the international community as non-
communicable diseases, are really manifestations of an auto-immune reaction to a 
transmissible microbial infection by Group A Streptococcus. Transmissibility is influenced 
by many factors, chief among them population density. The concept of “reciprocal 
determinism” is enshrined in social learning theory and states that human behaviors are 
shaped by interactions with other people as well as the environment, and, in turn, human 
behaviors influence other beings and the environment (Bandura, 1977). Overcrowding, 
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therefore, is a risk factor for GAS pharyngitis and subsequent RF/RHD. This has been 
documented in many populations including American army recruits who lived in barracks 
and indigenous populations in urban New Zealand (Davis & Schmidt, 1957; Jaine, 2011). 
Prevention can be augmented by improved interpersonal communication: providers should 
recommend screening services to patients and that parents, teachers and school nurses 
know how to recognize symptoms of strep throat and RF/RHD. In addition to encouraging 
provider recommendations, outreach by community workers and patient reminders for 
monthly BPG injections can improve compliance with secondary prophylaxis. Specialists 
must also counsel patients on medication use for heart failure and the importance of strict 
adherence to anticoagulation regimens. With the knowledge gained after education, 
patients attain the “behavioral capability” necessary to make positive health choices and 
develop the “self-efficacy,” or confidence, to do so. Moving forward, peer support groups 
would strengthen relationships amongst patients at the interpersonal level. 
Organizational level 
Diffusion of Innovations Theory (Rogers, 2003) can serve as a model to describe how 
clinical guidelines will be developed and disseminated to providers. In order to facilitate 
uptake, guidelines must be considered an upgrade over their predecessor—termed “relative 
advantage”—and considered a “fit” for implementation in the clinical setting. Ease of use, 
scalability and observability of results will dictate the magnitude of adaptation and 
therefore the success of innovation diffusion. The same theory can be used to plan the 
expansion of echocardiography into more remote regions of Nepal. Questions that must be 
answered include the relative advantage of echocardiography over conventional 
auscultation and the “fit” of the technology into the rural health care infrastructure.   
Organizational Change Theory can explain how guidelines are adopted, adhered to 
and institutionalized by health care professionals, their places of work and the larger health 
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care system. First, an organization must be willing to change and posses the capacity to 
transform (Weiner, 2009). Importantly, an innovation must align with the values of the 
instituting organization. Organizations, similarly to individuals, proceed through a step-
wise process that, if completed, results in the fidelitous implementation of innovations. 
Stages include defining the problem, adoption/piloting, implementation and, finally, 
institutionalization. This theory is relevant for the RF/RHD prevention plan because in 
order for a register-based disease tracking system to succeed, providers must buy-in to the 
data collection protocol, for example. Likewise, primary care providers must adhere to a 
standardized referral protocol if patient transfers to specialist care are to occur seamlessly.  
Community level 
Efforts should be taken to involve community members in program decision-making 
as indicated in Community Organization Theory in order to promote empowerment, local 
ownership and project sustainability. The theory is similar to the health beliefs model, but 
instead of focusing on barriers that dissuade positive health behaviors at the individual 
level, attention is focused on communities and systems. A needs assessment can identify 
common problems relating to a health issue; these problems then become the targets for 
intervention.  “Community competency” is another component of this theory. Education is 
critical in order to create and sustain community demand for clinical services relating to 
RF/RHD. Large-scale mass media campaigns to encourage service seeking for treatment of 
sore throat, for example, are necessary for primary prevention strategies to be successful. In 
Nepal, a documentary is frequently aired on a popular TV station, advertisements and 
interviews with medical professionals are broadcast on radio and celebrities are used to 
great effect to spread the message to large segments of the population. Smaller-scale efforts 
are targeted to high-risk populations like schoolchildren.  RHD has been integrated in 
curricula and unique modes of education have been promoted, including student-produced 
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dramas. Print media has also been widely distributed in various venues including schools 
and clinics. RHD awareness increased from 8% to 48% in schoolchildren and teachers 
thanks in part to the “Have a Heart, Save a Heart campaign” (Wyber, Regmi, 2013). Moving 
forward, dissemination of knowledge by trained and respected lay persons would foster a 
sense of fellowship in communities. 
Policy level 
 Government endorsement of a national RHD plan is crucial for program success. Not 
only does government ratification signal that RF/RHD prevention is a national priority, it 
also standardizes prevention practices across the country. An RHD plan does not exist in 
isolation, however. Its success is contingent on policies related to general health systems 
strengthening, the organization and structure of the health care system and social health 
insurance schemes. Even more than that, policies affecting the environment, economy, 
security, social welfare systems, education, housing, utilities and trash removal, 
occupational hazards and exposures as well as general anti-poverty campaigns, among 
others, will address some of the fundamental determinants of the population’s health.  
 
METHODS 
 As mentioned above, the RHD TIPS conceptual framework was used as a menu from 
which to identify prioritized interventions. The original framework was adapted to be more 
applicable to Nepalese context.  
Starting from the bottom of the framework, we first added “Hygiene” to the 
underlying risk factors for disease. We felt that all of the Baseline and Health Systems 
components were relevant to the Nepalese context and no changes were made to this 
section of the framework.  
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In the Primary Prevention row a few modifications were made. First, the “Active 
case finding (sore throat clinics)” box was re-titled as “School-based interventions.” The 
rationale for this change lies in the fact that schools can be a primary site for sore throat 
prevention (education, messaging) and treatment activities (symptom recognition, referral 
to school nurse or health worker, on-site dispensing of treatment). Drop-in sore throat 
clinics are likely not feasible in the Nepalese context, and neither is “active case finding” via 
throat swabbing and culture due to high cost and other logistical prohibitions. The second 
modification in the Primary Prevention row was the omission of the “Vaccine development” 
concept box. While Nepal would certainly benefit from a vaccine should it be created, 
vaccine development activities will be pursued outside of country. Nepal simply does not 
have the financial resources or basic science facilities to sustain a vaccine development 
program. This concept box was changed to “TP registry” to reflect the utility of a tonsillitis-
pharyngitis register as an epidemiological record, follow-up log and data collection tool for 
research purposes.  
In the Secondary Prevention row only one substantial change was made. The 
“Provision of secondary prophylaxis” concept box was merged with an additional concept: 
“Mitigation of fear of anaphylaxis.” Anaphylaxis is so feared by practitioners and patients in 
Nepal that BPG is not viewed as a viable option for sore throat treatment.  
“Advocacy” and “Awareness” were added to the top of the framework alongside 
“Research” as overarching and unifying concepts that should be considered throughout the 
design and implementation phases.  
The concept boxes highlighted in dark red with white text represent priorities for 
next steps interventions. First-line priorities include securing long-term and stable funding, 
design of a feasible program evaluation framework, creation of a Training of Trainers 
course, expansion of community education and awareness-raising campaigns, 
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implementation of school-based prevention and treatment activities, extension of active 
screening with echocardiography. 
Table 3. Adapted Version of RHD TIPS Conceptual Framework for RF/RHD 
Prevention 
 
We believe that these adaptations do not threaten or lessen the integrity of the 
framework. In fact, by adapting the framework to be more relevant to the Nepalese setting, 
we believe the utility of the framework has been enhanced, and is likely better suited to 
guide program design and planning in developing world countries generally. An 
intervention must be appropriate to the setting in which it will be implemented, as 
cataloged in Felipe Castro’s work on the tension between fidelity and adaptation of 
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An Adaptation Guideline Tool was created to aid program implementers in adapting 
evidence-based interventions to better fit their unique settings (Lesesne, 2007). This tool 
was used to sanction changes to the RHD TIPS conceptual framework, but a few important 
considerations need to be addressed: Frist, the conceptual framework is not an evidence-
based intervention per se; there is no research supporting its utility in any setting, even in 
the Western world. It is simply a guiding framework informed by past program experiences 
from around the world and by prevailing attitudes and judgments among the RF/RHD 
technical expert community. Second, there is no agreement over which components are 
“core” or essential to any functional RF/RHD prevention program. In fact, as outlined in the 
systematic review, countries have utilized widely different strategies to reduce and/or 
eradicate RF/RHD (see: Costa Rica and Samoa). Therefore, adaptation of the conceptual 
framework should not be bound be strict rules as depicted in the Adaptation Guideline Tool. 
The conceptual framework is better viewed as a menu of options from which to select 
interventions that are most relevant to a given program’s setting.  
 
GOALS AND OBJECTIVES 
Goal: To reduce morbidity and mortality due to RF/RHD in Nepal. 
Short-term Objectives: 
1. Perform local community needs assessments to identify barriers to RF/RHD care, 
both logistical barriers and those related to health beliefs.  
Activities: These assessments will be administered by month 3 and analyzed by month 6. 
Program implementers can use the information to address barriers in future program 
planning. Post-implementation surveys will be used to determine success of the efforts to 
tackle barriers. Participating patients and families should be invited to sit in on advisory 
committee meetings; some may even be permanent members on an advisory committee.  
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2. Develop standardized curriculum to “train trainers,” or program liaisons. 
RHD TIPS components addressed: Human resources, Health worker training. 
Activities: By year 1, Program implementers/experts will design the curriculum and lead 
training sessions. Educational materials will be created for trainees. Trainees will have 
some health care background and may include physicians, nurses or mid-level providers. 
Pre- and post-surveys will be used to measure trainee knowledge and skills before and after 
receiving education and skills training. 
3.  Trainers will disseminate RF/RHD prevention knowledge and skills in their local 
communities. 
RHD TIPS components addressed: Human resources, Health worker training, Community 
education. 
Activities: By year 3, one trained liaison will be present in each district throughout the 
country. They will be responsible for reporting local progress to program implementers, in 
this way acting as local “champions” for RHD control and prevention. In addition, they will 
be given necessary equipment and educational materials for dissemination into their 
communities.  
4. Establish “safe centers” for BPG administration of secondary prophylaxis at all 32 
NHF and government-run hospitals.  
RHD TIPS components addressed: Mitigate fear of anaphylaxis, Provision of secondary 
prophylaxis, RF/RHD register. 
Activities: This should be accomplished by year 1. Engage administrators at all hospitals and 
request dedication of one room to BPG administration. These rooms will be well-equipped 
with all necessary materials, including emergency kits for management of anaphylaxis. 
Patient compliance to secondary prophylaxis will be monitored. It is expected that 
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compliance will increase because wait times for patients needing injection will be 
dramatically reduced.  
5. Integration of RF/RHD prevention program into national non-communicable 
disease (NCD) plan. 
RHD TIPS components addressed: Funding, Government engagement, RF/RHD advisory 
committee. 
Activities: Accomplish by year 1. Engage stakeholders in government. Ensure that the 
RF/RHD plan aligns with the government’s values, mission and goals. Include government 
representative on advisory committee. Ensure continuous, sustainable funding for RF/RHD 
program and investment in procurement and delivery systems for necessary clinical 
supplies. 
Long-term Objectives: 
1. Decentralization of RF/RHD care and integration into primary care health system.  
RHD TIPS components addressed: Integration into primary care health system, Government 
engagement, Human resources, Provision of secondary prophylaxis. 
Activities: Begin by 6 months and accomplish by year 3-5. This process will occur in a 
diagonal manner, alongside general improvements in the Nepalese primary health care 
infrastructure. Physicians will be required to recognize signs and symptoms of RF and RHD 
and refer to specialist care if necessary. Because RHD often becomes manifest in pregnant 
women, integration with perinatal services is recommended. Task-shifting can dilute the 
distribution of secondary prophylaxis: in rural regions, providers as well as nurses and 
other mid-level providers can be trained to safely administer BPG and manage anaphylaxis 
if it occurs. School-based interventions can also be pursued. For example, teachers can be 
trained how to refer students with sore throat and school-based nurses can be trained to 
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administer antibiotics to children with sore throat. Furthermore, primary care staff are in a 
unique position to form close relationships with their patients, advocate for them, educate 
them and address risk factors for disease like overcrowding. A robust primary care health 
system is prerequisite in order for scale-up of primary prevention to succeed. Integration 
with existing care services is likely also a cost-effective manner in which to scale RF/RHD 
services.  
2. Expansion of echocardiographic screening to remote regions. 
RHD TIPS components addressed: Burden of disease data, Health worker training, Human 
resources, Active case-finding (echo screening). 
Activities: Accomplish by years 2-5. Better prevalence estimates are needed in rural and 
mountainous regions. This will help to prioritize regions for future interventions. 
Echocardiography is preferable to auscultation for screening due to its increased sensitivity 
and specificity. More Nepalese must become trained users of echo machines, reducing 
reliance of outside experts to complete screening campaigns. More portable echo machines 
are required to perform screenings throughout the country, which will require significant 
investment.  
3. Increase community awareness of RF/RHD prevention in Nepal. 
RHD TIPS components addressed: Community education; indirectly addresses health care 
service-seeking behavior related to all prevention strategies.  
Activities: Will occur continuously throughout duration of the program. Current awareness 
among students and teachers is approximately 50%, up from 8% just a few years ago thanks 
to large-scale awareness campaigns. Mass media (TV advertisements and documentaries, 
radio), print media (newspaper articles/advertisements, posters, pamphlets, brochures) 
and innovative techniques (plays put on by schoolchildren, songs, celebrity spokespersons) 
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and formal integration of RF/RHD health messaging into the national primary school 
curriculum—likely requiring partnership with Ministry of Education—will be employed. 
4. Continue full subsidization of secondary prophylaxis.  
RHD TIPS components addressed: Funding, Government engagement. 
Activities: Will occur continuously throughout duration of the program. Ensure financial 




The government of Nepal launched a program to prevent and control RF/RHD in 
2007. Since then, approximately 4 million Rupees ($40,854 USD) have been allocated 
annually to implement this program (Regmi, Program evaluation 2010). Additional grants 
from WHF, WHO and other NGOs and private businesses will be sought to help cover 
program costs, including materials and training. An estimated $10,000 USD/year will be 
raised. Over five years, the projected total budget is $254,270 USD.  
Short-term Goals 
1. Perform local community needs assessments to identify barriers to RF/RHD care, both 
logistical barriers and those related to health beliefs.  
$3,000 over first 3 months.  
a. Personnel: assessment developer(s), survey administrator(s) and analyst(s) 
b. Materials: printed surveys 
2. Develop standardized curriculum to “train trainers,” or program liaisons.  
$15,000 over first year. 
a. Personnel: curriculum developer(s) 
b. Materials: course plan, workbook, reference documents 
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3. Trainers to disseminate RF/RHD prevention knowledge and skills in their local 
communities.  
$30,000 from year 1 to year 3. 
a. Personnel: trainers 
b. Materials: education materials 
c. Equipment: start-up kit, including reference guides, clinical decision tools, 
BPG kits and administration instructions 
4. Establish “safe centers” for BPG administration of secondary prophylaxis at all 32 NHF 
and government-run hospitals.   
$38,270 over first 2 years.  
a. Personnel: staff including trained BPG administrators (likely nurses) 
b. Facilities: NHF and government-affiliated clinics and hospitals 
c. Training: for BPG administration and emergency anaphylaxis reversal 
d. Equipment: BPG kits and administration instructions, anaphylaxis kits 
5. Integration of RF/RHD prevention program into national non-communicable disease 
(NCD) plan.  
$1,000 in first year.  
a. Personnel: plan drafter(s), policy-makers in government 
Long-term Goals 
1. Decentralization of RF/RHD care.  
$40,000 from 6 months to 5 years. 
a. Personnel: primary care physicians, nursing staff, regional RF/RHD 
“champions,” school “champions” 
b. Facilities: capitalize on expanding primary health care infrastructure as well 
as Nepal Heart Foundation clinic sites; schools 
c. Equipment: BPG administration kits, oral antibiotics if necessary,  
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d. Materials: Print media for providers (diagnostic criteria for GAS pharyngitics 
and RF/RHD, referral protocol), teachers (recognition of signs/symptoms of 
RF/RHD), health care staff (BPG administration protocol) and patients. 
2. Expansion of echocardiographic screening to remote regions.  
$47,000 from year 2 to year 5.  
a. Personnel: trained echocardiographers; initially, some may need to be hired 
from outside the country 
b. Training: curriculum development for local echocardiographers, equipment 
repair 
c. Equipment: portable echo machines 
d. Transportation: fuel for screening campaigns  
3. Increase awareness of importance of RF/RHD prevention (seeking medical care for 
treatment of sore throat) in Nepal.  
$40,000 over all 5 years.  
a. Materials: print media (flyers, brochures, posters, newspaper columns, 
billboards); electronic media (radio, documentaries, TV programs) 
b. Advertising 
4. Continue fully subsidized secondary prophylaxis. 
 $40,000 over all 5 years.  
a. Financial commitment from government 
b. Materials: BPG procurement and administration equipment 
 
**Please see Appendix A for Logic Model** 
IV. EVALUATION PLAN 
EVALUATION CONTEXT 
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The Nepalese RF/RHD prevention program represents a significant investment by 
the government and offers great hope to many children and young adults in Nepal living 
with, or at risk of, developing RF/RHD. In addition, the program, if successful, could serve as 
a model for countries with similar challenges related to RF/RHD. For these reasons, it is 
important to determine whether the plan is being implemented as planned and achieving its 
intended outcomes, namely a decrease in the burden of disease attributable to RF/RHD. An 
evaluation plan, therefore, is needed to outline the manner in which the program’s activities 
are yielding or not producing its desired outcomes. The evaluation plan for the Nepalese 
RF/RHD prevention program carefully considers the program’s priorities and financial and 
human resource limitations in an effort to ensure that the evaluation can be feasibly 
executed (CDC, 2011). Two overarching forms of evaluation are necessary to monitor 
implementation fidelity (process evaluation) and achievement goals (impact evaluation). 
EVALUATION THEORY 
Traditional research designs and evaluation methodologies are often inadequate 
when applied to implementation science in the realm of public health (Kellogg Foundation, 
2004). All too often, evaluation efforts prioritize proving a program’s effectiveness rather 
than identifying ways in which a program’s activities can be improved. Mainstream 
evaluation methods are defined by, and inherently confined by, their ideological 
underpinnings rooted in the search for causality as defined by the scientific method. 
Programs are often multi-interventional, however, and the social contexts in which 
programs are implemented cannot be controlled for in the traditional sense. Because 
variables are not easily controlled for, traditional methods frequently can only answer 
whether or not a program was effective using quantitative pre/post implementation 
indicators; they cannot answer how or why or which components of a program were 
effective or not. A new, innovative form of research design called the “effectiveness-
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implementation hybrid design,” however, may be applicable to assessing the Nepalese 
RF/RHD program. Three forms of studies exist within the hybrid design: 1) testing clinical 
interventions against desired outcomes while observing how the clinical care is 
implemented, 2) testing clinical interventions and implementation strategies 
simultaneously, and 3) testing an implementation strategy while observing the effects of a 
clinical intervention on outcomes (Curran, 2012). Although a formal research study will not 
be designed, evaluation of the Nepalese RF/RHD prevention program could seek to mimic 
the second form of study in which both clinical effectiveness of certain interventions and 
the implementation process are coanalyzed.  
Due to the inherent deficiencies of traditional research designs as they relate to 
public health programs, this evaluation plan will incorporate alternative theories that focus 
on process measures and subjective experiences of program participants. Participatory 
evaluation emphasizes the importance of seeking stakeholder input from the outset and 
throughout the program’s implementation (Kellogg Foundation, 2004). An advisory 
committee composed of stakeholders from a variety of sectors—those who will actually use 
evaluation findings, those who are involved in program implementation and/or evaluation, 
and those directly served by the program—will be formed to design the evaluation plan 
(CDC, 2011). The evaluation plan will also be informed by a theory-based approach that 
requires the creation of an evaluation logic model. Based on the logic model, process 
indicators can be developed to monitor implementation fidelity. Program activities can then 
be modified in a dynamic fashion based on the data gleaned from ongoing monitoring 
efforts (Kellogg Foundation, 2004). The interpretivist/constructivist approach asserts that 
collected data should not only be quantitative; a mixed approach is preferred, and 
subjective program experiences should be sought from various perspectives—stakeholders, 
program staff and patients (Kellogg Foundation, 2004).  
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EVALUATION PLAN COMPONENTS 
Stakeholder Involvement 
Including stakeholders in the early design stages is consistent with the participatory 
evaluation model and increases understanding and acceptance of the evaluation process 
among participants, promotes participant buy-in and ensures transparency (CDC, 2011). 
The advisory committee for the Nepalese RF/RHD prevention program will consist of a 
program director, 2 program administrative staff (including 1 internal evaluator), 1 
external evaluator, 1 representative from government, 1 physician who sees RF/RHD 
patients, 1 patient receiving long-term BPG prophylaxis and 1 patient with experience 
receiving primary prophlyaxis treatment in the Lalitpur pilot program. Each member will 
bring a unique perspective to the table. Likely, the program director and government 
representative will take a broad, big-picture view of the successes and failures of the 
program. The physician, program staff and patients are likely to offer insightful subjective 
reports of experiences with administrative and point-of-care elements of the program, in 
fulfillment of interpretive/constructivist principles. Shared responsibilities may include 
setting goals and strategy, advocacy, fundraising, community engagement and 
education/advising.  
It will be important to foster an open, collegial and supportive atmosphere so that 
members feel empowered to offer opinions and suggestions throughout the evaluation 
process; this becomes especially important when monitoring data reveal deficiencies in a 
program and constructive conversations are required to improve program effectiveness. 
Conflicting expectations, goals and values must be addressed and resolved. At the initial 
stakeholder meeting, evaluation questions and focus, intended uses and users of evaluation 
data, and methods of evaluation will be agreed upon. Furthermore, the advisory committee 
will establish individual roles and responsibilities as well as meeting protocol, including 
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frequency of meetings, site of meetings and expectations of communication between 
meetings.   
Internal/external evaluators  
Ideally, both an internal and external evaluator will be utilized to monitor program 
implementation and impact.  As a member of program staff who may be responsible for 
implementing program activities, an internal evaluator has intimate knowledge of the 
program, direct access to data and, hopefully, is invested in program success. It is crucial 
that the evaluator is an individual with relevant evaluation credentials and expertise. If this 
is not possible, perhaps because no program staff has formal training in evaluation 
techniques, resources must be provided to the internal evaluator from an outside 
organization or expert in a technical advisory role. Evaluations performed by internal 
investigators are often prejudiced by bias: the evaluator may seek to “prove” that the 
program works and is affecting change, for example. Furthermore, the evaluator may feel 
overt or subtle pressure from his or her boss, in this case the program director or 
government representatives, to preferentially report positive over negative findings. These 
limitations, combined with the fact the Nepalese RF/RHD prevention program is a “high-
stakes” evaluation given the government’s oversight and funding, necessitate that an 
external evaluator be hired to evaluate the program in an unbiased and objective manner 
(Calleson, lecture notes). 
External evaluators do not have intimate knowledge of program implementation 
and delivery prior to their hiring. This naivety could be viewed as a deficiency, but it can 
also be valuable to have the eyes of an unbiased observer review monitoring and evaluation 
data; fresh insights and ideas can be offered to improve program delivery. The Nepalese 
RF/RHD prevention program would benefit from hiring an outside, private evaluator with a 
truly unbiased perspective because hiring an evaluator from government would represent a 
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conflict of interest as the government is funding the program. This evaluator must be an 
active listener in order to fully understand the goals of the program and values of program 
staff. Implementation is a messy business, so an evaluator must be flexible as deadlines 
change, staff turns over, funding streams are adjusted and unforeseen roadblocks are 
manifest. The evaluator(s) must be leaders so that their findings command recognition and 
attention (Calleson, lecture notes).  
Methods 
 Data collection will be an all-encompassing effort at all levels of the program. 
Indicator data must flow from decentralized, point-of-care program staff up into a 
centralized platform that is easily accessed by evaluators. The Nepalese RF/RHD prevention 
program has many components, all of which could be monitored by many indicators using 
both qualitative and quantitative methods. As is it impossible from both a human resources 
and budget standpoint to track all relevant process and impact indicators, the advisory 
committee will be tasked with prioritizing which indicators to monitor as well as how often 
to monitor them and the manner of their collection.  
Challenges 
Numerous challenges must be overcome in order for evaluation activities to be 
successful. Importantly, political instability is the norm in Nepal. Because the Nepalese 
RF/RHD program is funded primarily by government monies, the program must operate 
under the constant threat of funding cuts.  Even in the absence of political turmoil, however, 
budget restrictions are likely to constrain the intensity of evaluation efforts; only essential 
indicators are likely able to be monitored. Human resources may constitute a barrier, 
especially in the case of the internal evaluation. It remains to be seen if any program staff 
have formal training in evaluation techniques and data analysis. Furthermore, all program 
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staff will require training and guidance on how to collect and submit data to evaluators. 
Data collection resources, including reporting forms, submission protocols and survey 
instruments need to be developed and disseminated to program staff. Given the variety of 
program components and the large geographic scope of the Nepalese RF/RHD prevention 
program, the creation of these resources and their dissemination, the training of program 
staff, and the collection of data into one centralized database all constitute unique and 
sizeable challenges. Time is also a significant challenge. Unfortunately, program impacts are 
unlikely to be observed for a long time—trends in RF/RHD incidence and prevalence will 
likely take years, if not decades, to detect. Government allocations of funds for the RF/RHD 
prevention program, however, historically have been made on an annual basis. Program 
implementers, then, are under constant pressure to produce intermediate data showing 
immediate results.  
STUDY DESIGN AND METHODS 
Study design 
 The RF/RHD program’s overall design is quasi-experimental, specifically a non-
randomized pre/post design without a control group, also known as a “one-group 
pretest/posttest” (Issel, 2014): O1 X O2. The unit of observation for this study is not the 
individual, but rather the population. Indicators measuring RF/RHD disease burden before 
implementation (O1) will be compared to the same indicators after implementation (O2) of 
the program plan/intervention (X). Because RF/RHD rates of disease vary between regions 
and program activities may not be scaled throughout the entire country, it would be 
prudent to focus observations and indicator measurements to regions where program 
activities are implemented. The local impact of program activities, then, would not be 
diluted by consideration of the entire Nepalese population. An ecological study design could 
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be used, however, to compare trends in RF/RHD rates in Nepal versus other nearby and 
representative countries that are not implementing RF/RHD prevention activities. 
As with any study design, the pre/post design has pros and cons. A benefit of a 
pre/post design includes increased feasibility given the relatively low cost of 
administration. Many drawbacks exist, however, including an inability to control for secular 
trends and an inability to parse out the effects of individual interventions on the outcome(s) 
of interest. This is important because the Nepalese RF/RHD plan is a comprehensive plan 
with many interventions targeting many populations and points along the disease’s causal 
pathway. In this way, the relative effectiveness of any particular intervention in the RF/RHD 
program cannot be analyzed using a pre/post study. Additionally, it is impossible to 
attribute changes in indicator measurements directly to program activities because the 
study design does not allow for strict control of external (and internal) variables, thereby 
compromising internal validity (Trochim, 2006).  
Ideally, and if resources permit, other forms of quasi-experimental design could be 
utilized to evaluate components of the program. For example, an interrupted time series 
design could be utilized to evaluate the impact of trained liaison presence in local 
communities. In this design, observations are taken at regular intervals before, during and 
after implementation of a program component: O1 O2 O3 X O4 O5 O6 | O7 O8 O9 (Mercer, 
2007). In this case, the intervention (X) is the insertion of a trained liaison into a 
community. Observations are collected prior to the insertion of this trained liaison into the 
community in order to collect baseline data and to control of secular trends that may 
independently affect outcome measurements. Observations continue to be taken at regular 
frequencies during and after implementation. In addition, many research designs, including 
some experimental designs, could be used to determine whether the creation of “safe 
centers” for secondary prophylaxis administration improves patient outcomes and 
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population-level RF/RHD measures. For example, half of the country’s NHF hospitals (R1) 
could be randomized to establish safe centers (X) while the other half (R2) delivers 
secondary prophylaxis according to the status quo (no X): R1: X O1 O2 O3 versus R2 no X 
O1 O2 O3. A prospective cohort study could follow patients over time to determine if the 
patients receiving secondary prophylaxis from an NHF hospital with a safe center more 
faithfully adhere to treatment, experience fewer RF flares and have lower rates of 
progression to RHD. 
Methods 
 Various methods for data collection will be used, including internal program 
document and patient record review, observation and qualitative and quantitative 
techniques. Program staff and evaluators will be responsible for data gathering and 
administering data collection instruments.  
Qualitative methods will include unstructured interviews, focus groups, and written 
open-ended questions. Short-term goals 1-4 will be addressed using many of qualitative 
data collecting techniques. Program staff, health care providers as well as patients and 
caregivers will be participants in interviews and focus groups in order to get a holistic view 
of the program’s successes and/or failures. Individual experiences with the program, 
perceived program effectiveness, barriers to faithful implementation and suggestions for 
improvement will be identified during this process. Feedback from multiple sources at 
different points within the program will inform program activities in an iterative fashion. In 
this way, the program will undergo dynamic change as feedback is fed back into program 
design in order to improve service delivery.  
Quantitative methods will include closed survey analysis, counting and frequency 
measurements. Counting and frequency measurements may be derived from internal 
review of program files, review of patient medical records and disease registries as well as 
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review of echocardiographic screening data, polling data and needs assessment results. 
Most of the long-term goals will be assessed using quantitative data analysis, specifically, 
decentralization of RF/RHD care, expansion of echocardiographic screening, and 
awareness-raising campaigns.  
EVALUATION PLANNING TABLES 
Short Term Objective #1: Perform local community needs assessments to identify barriers to 
RF/RHD care, both logistical barriers and those related to health beliefs. 
EVALUATION QUESTIONS PARTICIPANT METHODS 
By 3 months, were community 
needs assessments created and 
administered? 
Program staff  
 
Document review  
How will communities and 
community members know 
about the needs assessment? 
Program staff Documentation of print media 
distribution, telephone 
reminders 
How many communities were 
contacted to complete needs 
assessment? How many 
communities completed the 
needs assessment? How many 
needs assessments were 
collected? 
Program staff Data collection and review of 
needs assessments 
In each community, was the 
needs assessment completed by 
a member of each: program 
staff, physician/health care 
worker, patient/patient’s 
caregiver?  
Program staff Review of needs assessments 
What were perceived barriers 
to administering RF/RHD care? 
Program staff 
Needs assessment 
participants (local health 
care professionals, local 
program staff) 
Review of needs assessments 
Focus groups 
Interviews 
What were perceived barriers 






Review of needs assessments 
Focus groups 
Interviews 
What suggestions did 
community members provide to 
Program staff 
Needs assessment 
Review of needs assessments 
Focus groups 
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improve RF/RHD service 
delivery? 
participants (health care 
workers, program staff, 





Short-Term Objective #2: Develop standardized curriculum to “train trainers,” or program 
liaisons. 
EVALUATION QUESTIONS PARTICIPANT METHODS 
By 1 year, was a curriculum 
devised? 
Program staff Document review 
Did the program implementers 
meet with experts to 




Minutes from committee meetings 
Documentation of sources providing 
technical expertise 
Was a survey created and 
administered to assess trainee 






Documentation of participants’ pre-
intervention knowledge and skill 
level 
Was a survey created and 
administered to assess trainee 
post-intervention knowledge and 





Documentation of participants’ post-
intervention knowledge and skill 
levels 
Were trainees satisfied with the 
training? Do trainees feel 
prepared to serve as a program 
liaison in their home districts 
after training? What 
recommendations do trainees 
have to improve the training? 
Program staff 
Trainees 
Written open-ended questions 
Focus groups 
Interviews 
Were educators satisfied with the 
content and structure of the 
training? What recommendations 




Written open-ended questions 
Focus groups 
Interviews 
Was the training effective?  Program staff 
Trainees 
Trainers 
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Short-Term Objective #3: Liaisons will disseminate RF/RHD prevention knowledge and 
skills in their local communities and give regular reports to program implementers. 
EVALUATION QUESTIONS PARTICIPANT METHODS 
Between years 1 and 3 did 
liaisons disseminate 
knowledge and skills into 
their local communities?  
Program staff 
Liaisons 
Documentation of liaison presence 
in communities 
Documentation of liaison RF/RHD 
promotional activities 
Are program liaisons present 
in every district in the 
country?  
Program staff Documentation of liaison presence 
in communities 
 
Do liaisons feel equipped to 
address RF/RHD needs in 
their districts? What were 
some challenges 
encountered with regard to 
starting and or scaling 
RF/RHD prevention efforts? 
Program staff 
Liaisons 
Written open-ended questions 
Interviews 
Focus groups 
Are liaisons regularly 
reporting RF/RHD data from 





Documentation of reports 
What techniques did liaisons 
use to disseminate their 
knowledge and skills into 
their home communities? 
Which were most effective? 
Program staff 
Liaisons 
Review of liaisons’ reports 
Written-open ended questions 
Interviews 
What was the liaison’s 
impact? 
Program staff Quantitative data review: # of 
RF/RHD referrals; # of identified 
RF/RH cases; # of patients 
receiving care; # of clinics 
providing RF/RHD services 
  
 
Short-Term Objective #4: Establish “safe centers” for BPG administration of secondary 
prophylaxis at all 32 NHF and government-run hospitals. 
EVALUATION QUESTIONS PARTICIPANT METHODS 
By year 1 were “safe 
centers” established at all 
NHF government-run 
hospitals? 
 Program staff Documentation of establishment 
of safe centers in NHF hospitals 
Are safe centers properly Program staff Data collection 
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equipped and staffed? Local staff Documentation of site-specific 
equipment 
Interviews with local staff 
Have safe centers 
improved efficiency of 
delivery of secondary 
prophylaxis? The cost-




Data collection: quantitative 
review of registry records (# of 
patients seen, # BPG injections 
administered, # of incident cases 
of RF/RHD in community) 
Interviews with local staff 
Review of budget, financial 
records 
Are patients and caregivers 
aware of safe centers? How 
are they made aware? 
Program staff 
RF/RHD patients and 
caregivers 
 
Documentation of distribution of 
print media 
Quantitative review of patient 
usage of safe centers 
Do patients, caregivers and 
staff approve of the safe 





RF/RHD patients and 
caregivers 
Written open-ended questions 
Focus groups 
Interviews 
What innovations can be 
implemented to improve 




RF/RHD patients and 
caregivers 
Written open-ended questions 
Focus groups 
Interviews 
Is it possible to scale the 
model to non-NHF 
hospitals and clinics? 
Program staff 
Local staff 
Quantitative and qualitative 
analysis of safe center success 
Reconciliation of safe center cost-
effectiveness and program budget 
Environmental scan to determine 
where to scale next, if determined 
to be feasible 
What was the impact of 
creating safe centers? 
Program staff Quantitative data analysis: % of 
patients regularly receiving 
prophylaxis; rates of RF flares 
among patients; rate of 




Short-Term Objective #5: Integrate RF/RHD prevention program into national non-
communicable disease (NCD) plan. 
EVALUATION QUESTIONS PARTICIPANT METHODS 
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By year 1 was a RF/RHD 
prevention program 
incorporated into a national non-
communicable disease plan? 
Program staff 
Government 
Documentation of integration of 
RF/RHD program into national 
NCD plan 
Was an advisory committee 
composed of government 
officials, program implementers, 
health care professionals, 
evaluators and 
patients/caregivers assembled 
to inform program 
development? 
 Program staff 
Stakeholders 
Minutes from advisory committee 
meetings 
Documentation of stakeholder 
attendance at meetings 
Were concrete goals, a budget 
and timeline agreed upon? 
 Program staff Minutes from advisory committee 
meetings 
Review of RF/RHD program plan 
What was the impact of RF/RHD 
integration into the national NCD 
plan? 






Long-Term Objective #1: Decentralize RF/RHD care and integrate into primary care health 
system.  
 
EVALUATION QUESTIONS PARTICIPANT METHODS 
Are constant efforts being made 
to decentralize RF/RHD 
prevention to smaller and 
smaller health posts? 
Program staff Log of participating clinics and 
health centers 
Documentation of 
communication/outreach efforts to 
clinics, health centers and 
community leaders 
Is decentralization occurring? Program staff 
Local staff 
Data collection 
Log of participating clinics and 
health centers 
Are partnerships being sought 
within the expanding and 






communication/outreach efforts to 
clinics and health centers, schools 
and potential service delivery 
partners 
 
Is task-shifting occurring in 
order to facilitate RF/RHD 
Program staff 
Liaisons 
Review of liaison reports, 
highlighting transfer of knowledge 
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prevention activities in 
currently underserved areas? 
initiatives 
Medical record and registry review 
Are schools increasingly a site 
of RF/RHD prevention? Are 
teachers being taught to 
identify sore throat and 
RF/RHD symptoms and refer 
students to appropriate medical 
professionals? Are students 
taught to report sore throat to 




Documentation of distribution of 
print media to schools 
Teacher and headmaster interviews 
Curriculum review 
Review of liaison reports 
 
In discussions of primary health 
care infrastructure in 
government, is RF/RHD 
highlighted as a disease that 
would benefit from increasing 




Number of relevant parliamentary 
meetings attended by program staff 
Documentation of communication 
with members of parliament 
Identification of an “RHD champion” 
in government 
Documentation of partnerships and 
lobbying efforts with like-minded 
organizations and individuals 
  
 
Long-Term Objective #2: Expand echocardiographic screening to remote regions. 
 
EVALUATION QUESTIONS PARTICIPANT METHODS 
By years 2 to 5 has use of 
echocardiographic technology 
been expanded into previously 
un-served regions? 
Program staff Data collection 
Documentation of screening 
campaigns in previously 
underserved areas 
How many regions now have 
access to echocardiography? In 
how many regions have 
screening campaigns taken 
place? 
Program staff Data collection 
Documentation of screening 
campaigns 
Review of records 
Are Nepalese professionals 
being trained as 
echocardiographers in order to 
decrease dependence on 
outside expertise? How many 
have been trained? 
Program staff Quantitative review of: # of echo 
training programs available to 
professionals, # of professionals 
enrolled in these programs 
Creation or adaption of a training 
curriculum 
Are more echocardiographic 
machines available for 
screening campaigns? 
Program staff Product purchase records 
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Because of screening 
campaigns that reveal regional 
RF/RHD prevalence estimates, 
have certain regions of the 
country been identified as 
priority regions for 
intervention?  
Program staff Data collection 




Long-Term Objective #3: Increase awareness of RF/RHD prevention in Nepal over baseline 
(seeking care for treatment of sore throat).  
 
EVALUATION QUESTIONS PARTICIPANTS METHODS 
 By year 5 are awareness rates 
for RF/RHD prevention 
services and positive behaviors 




Survey administration  
Data collection and review of 
survey poll results 
What behaviors have been 
targeted? What are the 
primary messages delivered?  
Program staff Content review of awareness 
materials 





Content review of awareness 
materials 
Evidence of tailored campaigns to 
different high-risk groups 
How were audiences targeted? 
(Print media, mass media, 
dramas) 
Program staff Data collection 
Review of different methods used 
to raise awareness 
  
 
Long-Term Objective #4: Continue full subsidization of secondary prophylaxis.  
EVALUATION QUESTIONS PARTICIPANTS EVALUATION METHODS 
Is secondary prophylaxis 
fully subsidized by the 
government?  
Program staff Review of government RF/RHD 
health budget 
Is there political resistance 







Are long-term contracts for 
BPG procurement and 
delivery in place? 
Program staff Review of government 
procurement contracts 
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DISSEMINATION 
 From the outset in the design stages of the evaluation plan, it is important to 
consider for whom the evaluation is being conducted. In this case, the evaluation is being 
performed primarily for the Nepalese government as the primary funders of the program, 
as well as for program administrators who can use the evaluation data to change 
implementation strategies in a dynamic manner. Additionally, the program could be a 
model for other countries if successful. Therefore, the program has the responsibility to 
accurately collect implementation data and identify key program components that could 
then become part of a large, evidence-based implementation strategy for RF/RHD 
prevention in similar countries.  
Dissemination will occur on two levels during and after implementation of the 
RF/RHD plan. First, during implementation recommendations from the RHD TIPS handbook 
will be disseminated and manifested in the program design. Awareness campaigns will also 
disseminate positive health messages throughout the program in order to improve health 
care seeking behaviors as well as general knowledge about RF/RHD. Via trained liaisons, 
accepted clinical and public health interventions will be spread to every region in the 
country. Capacity for echocardiographic screening will be enhanced and the technology 
disseminated to regions of the country heretofore unexposed to the screening tool. In short, 
the RF/RHD program itself is dissemination and implementation plan designed to improve 
the way RF/RHD care is delivered and expand the scope of service delivery. Second, 
evaluation findings will be disseminated both internally to program staff and externally to 
stakeholders and the general public.  
 Evaluation is a process by which success of dissemination and fidelity of 
implementation can be measured. Before evaluation even begins, it is important to consider 
to whom the results will be disseminated (Kellogg Foundation, 2004). In this case, process 
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evaluation findings will be relayed internally to program administrators. It should be a 
dynamic process in which evaluation findings drive future program activities and design 
(Issel, 2014; CDC 2011). Ideally, evaluators should disclose findings early and frequently so 
that administrators can quickly act on the findings and so that staff and stakeholders feel 
invested (Kellogg Foundation, 2004). An impact evaluation will be completed at the end of 
the study and findings will be disclosed to various stakeholders, including the government, 
and perhaps the public at large.  
In addition, it is important to consider how the results of the evaluation will be 
disseminated, both to program administrators, staff and stakeholders, as well as the 
scientific community and general public if it is decided that program findings should 
contribute to the general fund of knowledge. In what form will evaluations be disseminated 
(Issel, 2014): reports, presentations at advisory committee meetings, peer-reviewed 
journal, et cetera? Dissemination must be tailored to the targeted audience(s)(CDC, 2011). 
Regardless of the format, evaluation findings should always be reported in the context of 
the program’s aims and objectives.  
Mechanisms must be in place to assure the quality of the evaluations (CDC, 2011). 
Hiring both an internal and external evaluator is one way in which to check the accuracy of 
the evaluations, especially when an unbiased evaluator is required in a “high-stakes” 
evaluation as is the case with the RF/RHD program whose funding comes from outside 
sources (Calleson, lecture notes). Another way to ensure evaluation quality is to develop a 
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V. CONCLUSION 
 RF/RHD is a major burden of suffering, especially for children and young adults, in 
Nepal as well as many other countries (Maurice, 2013; Roberts, 2013; Carapetis, 2000; 
Carapetis, 2005). A refusal to curb RF/RHD is regrettable and immoral because it is a 
preventable disease. The benefits of RF/RHD prevention are numerous, ranging from 
decreased burden of suffering to cost savings for stakeholders. In 2013, the World Health 
Assembly included RF/RHD as a disease to be incorporated into national non-
communicable disease plans. This development offers a wonderful opportunity for RHD 
advocates to bring RF/RHD to the attention of policy-makers and Ministries of Health 
around the world.  
A systematic literature review identified past and extant RF/RHD prevention 
programs at the national level. Review of these model programs revealed that RF/RHD 
prevention can be approached successfully in a multitude of ways. Costa Rica, for example, 
was able to essentially eradicate RF/RHD using primary prevention interventions 
(Arguedas & Mohs, 1992). On the other hand, Samoa has dramatically reduced the RF/RHD 
burden of suffering by focusing on secondary prevention via echocardiographic screening 
(Viali, 2006; Viali & Saena & Futi, 2011; Steer, & Colquhoun & Viali, 2006). Local 
circumstances, national priorities and resource availability dictate the extent to which 
countries focus on specific prevention strategies: primary prevention worked in Costa Rica 
because of an ideological emphasis on primary health care, and secondary prevention 
works in Samoa because universal echo screening in a subset of school-aged children is 
feasible. Because of its unique situation, Nepal is likely to benefit most from a hybrid plan, 
one in which many strategies act synergistically to maximize RF/RHD prevention efforts. 
These disease-specific efforts will occur within the context of an expanding primary health 
care system in a so-called “diagonal” manner.  
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 The goal of the Nepalese RF/RHD prevention plan is to reduce the burden of 
suffering attributable to RF/RHD. As the RHD TIPS toolkit recommends, various prevention 
strategies targeting different populations and points along the disease’s causal pathway 
were highlighted in this paper. Components of the adapted RHD TIPS conceptual framework 
were prioritized for intervention according to need and resource realities, and short- and 
long-term objectives were built around identified gaps and opportunities. In turn, the short- 
and long-term objectives each addressed various components of the adapted RHD TIPS 
conceptual framework.  
Many levels of the Social Ecological model are targeted by the program plan, and 
various theories are used to inform program design at each level. For example, the Health 
Beliefs model will be used at the individual and community levels to identify perceived 
barriers to ideal service-seeking behavior and utilization of health care services. Community 
Organization theory will guide the solicitation of opinions and experiences of community 
members, patients and caregivers in the design, implementation and evaluation phases. 
Feedback will be fed back into the program design and improvement processes.  
 Evaluation of the Nepalese RF/RHD program plan is crucial for many reasons. First, 
it is important to know whether the interventions are being implemented faithfully. Second, 
it is important to know if the faithful implementation of interventions leads to improved 
outcomes, in this case a reduction in the burden of disease attributable to RF/RHD. Third, it 
is important to secure future funding and stakeholder buy-in. Fourth, because Nepal is a 
pilot country for the RHD TIPS handbook, it is important to gauge the toolkit’s utility. Fifth, 
results from Nepal may inform program development in other countries, therefore program 
implementers are responsible for collecting quality data if they believe that their program 
can be replicated successfully in other countries. It remains to be seen to what extent the 
program or its components can be turned into a research study; if resources permit, studies 
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could be designed to determine the fidelity of the interventions’ implementation as well as 
the relative effectiveness of interventions on outcomes.  
 Evaluation indicators were carefully selected and based on key evaluation 
questions, which were, in turn, informed by program goals and short- and long-term 
objectives. It remains to be seen whether the capacity exists to successfully carry out the 
evaluation using all indicators as represented in the program plan. Should resources, both 
financial and human, forbid the monitoring of all indicators, program implementers will be 
forced to prioritize which indicators to monitor. 
 Success is dependent on many factors, some internal to the program and other 
external forces. Program implementers and staff must be enthusiastic and dedicated to the 
program’s goals and objectives. Stakeholders must be involved in the design stage and 
regularly briefed during the implementation and evaluation phases in order to foster trust 
and program legitimacy, enhance buy-in, and keep funding streams open. Indeed, funding is 
crucial to any program. In Nepal, the majority of program funds will come from a politically 
unstable government, which may necessitate flexibility and adaptation from the 
implementation team. Long-term program success depends on a dependable long-term 
source of funding. Furthermore, human resource shortages, staff under-qualification and 
time constraints constitute challenges for both the implementation and evaluation 
components of the program. 
 Despite immense challenges, the Nepalese RF/RHD prevention plan provides a 
roadmap for the reduction of the RF/RHD-attributable disease burden in the country. In 
addition, the program—should it prove to be successful—may both validate the RHD TIPS 
handbook as an effective tool to guide program design and serve as a model program for 
other countries wishing to institute national RF/RHD plans. The program’s generalizability 
will be largely dependent on the quality of the program’s evaluation.   
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Appendix A: Program Logic Model 
GOAL:  To reduce morbidity and mortality due to RF/RHD in Nepal. 
























 Perform local community 
needs assessment to identify 
barriers, including health 
beliefs and logistical 
 “Trainer training”: Develop 
standardized curriculum and 
train community HCW 
champions to disseminate 
RF/RHD knowledge into their 
communities including 
RF/RHD diagnosis, 
management, proper referral 
and safe injection practices for 
BPG administration 
 Awareness campaigns: mass 
media, small print media and 
innovative techniques, like 
school plays: focus on 
elementary school teachers, 
students and parents 
 Identify/engage local 
leaders/champions 
 
 Report on community 
barriers to RF/RHD 
preventive care 
 Increased HCW 
knowledge and skills 
needed to treat 
and/or prevent 
RF/RHD 













 At least 1 trained 
HCW in each 
district 
 Increase in 
community 
awareness over 
current to 80% 
(currently 48%) 












 RF/RHD program 
activities in every 







 Reduced cost 
to health care 
system from 
RF/RHD 

































 Form an advisory committee 
with members from: NHF, 
government, RF/RHD patients 
and their families, outside 
experts 
 Progress reports to be 
submitted to government by 
NHF 
 Engage school leaders for 
screening campaigns and 
school-based primary 
prophylaxis campaigns 
 Integration of RF/RHD health 
messaging into elementary 
school curriculum (could 
partner with Ministry of 
Education) 
 Continue echocardiographic 
prevalence studies throughout 
country 
 Standardization of patient 
referral process and priority-
based follow-up care 
 Procure/distribute supplies to 
local hospitals and clinics 
 
Primary prevention: 
 Development of 
RF/RHD prevention 
plan 
 Semi-annual advisory 
committee meetings 
 Annual progress 
reports 
 Increase in number of 
schools with access 
to echocardiographic 
screening 
 Creation of RF/RHD 
curriculum for 
elementary school 




burden of disease 
 Decrease in number 
of patients lost to 
follow-up 
 Reliable and quality 
procurement system 
and supply chain 
 






national NCD plan 
 Increase by 3-fold 
the number of 
schools with echo 
screening 













regions of the 
country 
 100% provider 
understanding of 
referral process 
 Pilot of protocol to 
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 Integration into strengthening 
primary care system 
 Scale Lalitpur program to 
other states throughout 
country 
 Perform post-implementation 
survey of Lalitpur program 
participants: staff, patients, 
parents, providers 
 Perform epidemiologic studies 
on GAS pharyngitis 
presentation, incidence, 
natural history; RF incidence, 
presentation 
 Creation and maintenance of 
standardized tonsillitis and 
pharyngitis register 
 Development of GAS 
pharyngitis clinical diagnostic 
algorithm 
 Cost-effectiveness analysis of 




 Ensure registry compliance 
 Establishment of “safe centers” 
for BPG administration 
 Perform internal audits: cases 
detected, BPG administered, 
patient compliance rates, etc 
 Anti-anaphylaxis measures: 
train HCWs to manage 
anaphylaxis, have emergency 
kit handy with every injection, 
standardize safe injection 
practices 
 Scale echocardiographic 
campaigns to remote regions 
of the county 
 Train national 
echocardiographers 
 Purchase portable echo 
machines 
 Increased number of 
functioning primary 
prevention programs 
 Understanding of 
subjective and 
objective successes 




understanding of GAS 
epidemiology in 
Nepal 
 CEA report on “treat-
all” clinical approach 
and development of 
clinical diagnostic 
algorithm if approach 
is subpar 
 




 Decrease in rate of 
anaphylactic 
reactions 
 Reduction in 
percentage of 




 Creation of “safe 
centers” at hospitals 
and clinics for BPG 
administration 
 Expansion of anti-
anaphylaxis 
trainings 
 Increase in number 
of providers trained 
to use echo for RHD 
diagnosis 
 Increase in number 
of echo machines 
 Increase in number 
of children screened 
for RHD 
monitor quality of 
imported BPG 
 
 Establishment of 
at least 1 primary 
prevention 
program in rural 
region of Nepal 
 Report on 
epidemiology of 
GAS pharyngitis in 
Lalitpur 




treatment of sore 
throat 
 100% provider 
compliance with 
standardized 
registry for GAS 
pharyngitis and RF 
 




 Establishment of 
“safe centers” for 
BPG 
administration in 
all 32 public 
hospitals 
 0% provider 
refusal rate to 
administer BPG 
 0 deaths due to 
anaphylaxis 
 Decrease rate of 
recurrent RF by 
50% 
 Training of 5 
national 
echocardiographe
rs to diagnose 
RHD 
 50% students 
screened with 




 Formal integration 





 >90% provider 
















 Lobby government to include 
long-term RF/RHD program 
funding in national NCD plan 
 Work with advisory committee 
members to establish a 
fundraising strategy 
 Assess Rotary International’s 
willingness to help fund 
scaling of primary prevention 
projects 
 Assess willingness of NGOs 
(like WHF) to fund training 
and education materials 






 RHD TIPS 
handbook 
 Use RHD TIPS handbook as a 
guide for program 
development 





 Increase in HCW 
knowledge and skills 























 Small print 
media 
 Billboards 


















using existing NHF and 
national primary care 
infrastructure 
 Expand RF/RHD education into 
communities and schools 
 Rely on existing procurement 
and distribution systems for 
clinical supplies 
 Standardize training resources 
 Use focus groups to pre-test 
effectiveness of various 
awareness-raising mechanisms 
 Increase in general 








out by Nepalese 
experts 
 Decentralization 
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provided with materials 
from WHO as well as 
modest financial backing 
in exchange for regular 
reporting to WHO. Project 
rolled out in 3 phases: 
pilot, regional, national. 
 
Focus on provider and 
patient education as well 
as secondary prevention 
(active case-finding using 
non-echocardiographic 
methods, registry creation, 
































Standardization of reporting. 
 
Weaknesses: 




reported regionally).  




Goal: To reduce 
incidence of 





5-14) in Costa 
Rica. 
“Diagonal” approach in 
which primary prevention 
(early detection and 
treatment of GAS sore 
throat) is delivered within 
a strengthening primary 
health care system.  
 
Focus on provider 
education of clinical 







adverse effects to 
treatment and GAS 
resistance to BPG.  
Rapid and 
sustained 







Strong government support. 
“Diagonal” approach. 
Decentralization of care. 
Development of cost-
effective clinical diagnostic 
criteria. 
Weaknesses: 
Lack of a robust evaluation 
procedure. 











Goal: To reduce 
incidence of 








screening in schools, 
registry, long-term 
prophylaxis with BPG) 
with ancillary primary 
prevention activities 
(school-based; teachers 
refer students with sore 
throats to providers). 
 
Provider, patient, 
























Organized referral service. 
Electronic registry. 
Good coverage with echo 
screening. 
Partnerships with MofE, 
international NGOs, foreign 
experts and companies. 
Targeted roll-out of primary 
prevention to high-risk 
schools. 
Weaknesses: 
Lack of robust monitoring 
and evaluation framework. 
Difficult to determine which 
program component is 












soon to be 




Ancillary tertiary care 
services with Team Heart 
from USA.  
 
Provider, patient, 
community education and 
awareness. 
 








Collaboration with MofE and 
integration in national NCD 
plan. 
Innovative methods of 
reaching patients. 
Weaknesses: 
Lack of focus on health 









Development of remote 
consult services. 
systems strengthening and 
primordial/primary 
prevention. 
Questionable scalability and 
sustainability. 
Lack of disease register. 





1) To “achieve 
equity of incidence 





and other New 
Zealand children.” 
2) To “contribute 
to the reduction of 
the age-
standardized 
annual rate of 
rheumatic fever 
among Māori and 
Pacific peoples, 
other New 











including school-based and 




including research on 
disease prevalence. 
 
Funding for vaccine 
development.  
 
Provider, patient, caregiver 
and community education 





































links have been 
strengthened.  
Anecdotal 
reports of high 
GAS detection. 
Strengths: 
Government support.  




primary and secondary 
prevention. 
Innovative school and drop-
in sore throat clinics. 
Robust evaluation 
framework incorporated into 
program plan. 
Clear, measurable goals and 
objectives. 
Targeted towards high-risk 
populations. 
Recommendations for 
improvement solicited from 
community members. 
Weaknesses: 
No identified theoretical 









to 0.4 per 100,000 
by 2020.” 
3) To “contribute 
to the reduction of 
rheumatic fever 
recurrence in New 
Zealand to five 
cases 
or fewer per 
annum by 2013.” 









model to guide program 
design. 
Difficult to discern the 
relative contribution of each 
program component to 
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Appendix C: Project Timeline 
 
 
Short-term Goals Start 3 Months 6 Months 1 Year 2 years 3 years 4 Years 5 Years Total Cost
1. Perform local community needs assessments to identify 
barriers to RF/RHD care, both logistical barriers and those 
related to health beliefs. $3,000
2. Develop standardized curriculum to “train trainers” or 
program liaisons in rural areas. 
$15,000
3. Trainees return to their home districts and disseminate 
RF/RHD prevention knowledge and skills.
$30,000
4. Establish “safe centers” for BPG administration of 
secondary prophylaxis at all 32 NHF and government-run 
hospitals. $38,270
5. Integration of RF/RHD prevention program into national 
non-communicable disease (NCD) plan.
$1,000
Long-term Goals Total $87,270
1. Decentralization of RF/RHD care. 
$40,000
2. Expansion of echocardiographic screening to remote 
regions.
$47,000
3. Awareness of importance of RF/RHD prevention (seeking 
medical care for treatment of sore throat) ~100% among 
students and teachers in Nepal. $40,000





Personnel: $15,000                                                                                    
Training: $5,000                                                                                       
Eqipment: $18,270
Personnel: $1,500                                  
Materials: $1,500
Personnel: $8,000                                                          
Materials: $7,000
Personnel: $5,000                             
Materials: $5,000                                
Equipment: $20,000                         
BPG procurement and BPG administration equipment
Personnel: $1,000
Personnel: $10,000                                                                                              
Equipment: $20,000                                                                                                              
Materials: $10,000                                          
Personnel: $20,000                                                                  
Equipment: $20,000                                                   
Materials: $7,000
Materials: $20,000                                                                                                                                                     
Advertising: $20,000
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Appendix D: IRB Considerations 
 The RF/RHD program plan will include data collection activities that involve human 
subjects. Therefore, Institutional Review Board endorsement will be needed for ethical 
approval of program activities carried out by myself or other UNC personnel. Hopefully, 
however, local Nepalese program staff will perform the program evaluation. In Nepal, a 
separate entity exists for research study approval, the Nepal Health Research Council’s 
Ethics Review Board (NHRC ERB) (Harvard, 2006). The NHRC ERB must directly approve 
any projects being implemented at the national level, like the national RF/RHD plan.  good 
Qualitative research  
Qualitative research techniques including interviews, surveys, focus groups and 
written open-ended questions will be used to gather data relevant to program activities 
throughout the study. Subjects will include program staff, health care providers as well as 
patients, many of whom will be under 18 years of age, and their caregivers. Human subjects 
will be recruited in a non-coercive manner, and informed consent will be attained via 
education from program staff and a study fact sheet. Participation will be strictly non-
voluntary. Program aims and goals as well how evaluators use participants’ responses will 
be shared with participants (Calleson, n.d.c). Program staff will be assured that their 
responses will not affect their employment status. Avenues will be opened for study 
participants to contact evaluators with questions or concerns.  
The risks for participants in the qualitative procedures are few because 1) there is 
no threat of corporal harm and, 2) the risk of psychological harm is low due to the fact that 
RF/RHD is not a highly stigmatized disease, there is no criminal or civil liability related to a 
RF/RHD diagnosis and there is no risk of damaging a participant’s employment status. 
It will be difficult to assure full protection of confidentiality. It is likely that certain 
study participants, especially health care professionals and program staff, may be easily 
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indirectly identified via linked identifiers. Furthermore, it will be important to link 
responses in qualitative procedures to the respondents in order to analyze discrepancies in 
the perceptions of program implementers and beneficiaries; in this way, data cannot be de-
linked from the respondent. Every effort will be made to include only relevant patient 
identifiers, and, as mentioned above, there is very little risk to participants even if their 
responses are disclosed. Only program evaluators will have access to raw data linking 
individual respondents to their responses; only aggregated data will be available to other 
program staff and stakeholders.  
All survey, interview and focus group responses will be collected for internal 
purposes with the goal of improving program effectiveness. It is unlikely that responses will 
be used and published in a peer-reviewed research article. Therefore, data derived from 
these methods is not considered “research” because it will not contribute to the general 
public fund of knowledge.  For this reason, it is unlikely that these qualitative instruments 
would require full IRB review. A fast-track exemption should be sought in this case.  
Liaison training and “safe centers” for secondary prophylaxis administration 
Pre- and post-surveys of liaison trainers and trainees will abide by the informed 
consent process described above. It might be prudent for the program to evaluate and 
report on the effectiveness of the training program, making the results open to the general 
public. In, this way, this particular component of the program may be considered research 
and it is likely that study design and materials would require full IRB review. It would be 
necessary for evaluators to undergo Human Subjects Training, which covers consent 
requirements and ethical considerations, among many other competencies (UNC, 2013).  
Similarly, the effectiveness of safe centers for secondary prophylaxis administration 
could be studied relative to the standard of care. As mentioned in the Methods section, many 
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study designs, including a prospective cohort trial, could be used to answer this study 
question. If program staff pursues this study, full IRB review will be required.  
 
